WHO 2019 NCoV Vaccine Deployment Tool 2021.2 Eng

 
NAVIGATION BAR: Menu Next Page
A1. WELCOME to COVID-19 Vaccine Introduction and deployment Costing tool (CVIC Too
Language Selection English
If you change the language, please review all dropdown menu responses to ensure they a
A1.1 Updates and Disclaimer
Version 2.1
Last Update (Tool) 10 May 2021
Please note that default unit prices, incl. for vaccine related supplies, are unstable du
Notice: conditions and vaccine specifications are preliminary and indicative only. SUBJECT
CHANGE.
Last Update (Vaccine database) 26 February 2021
This is a COVID-19 vaccination costing estimation tool: The tool is meant to help govern
partners, and other stakeholders estimate the introductory and deployment cost of COVID
procurement and service delivery, before detailed planning can take place. These costs inc
activities, international and domestic logistics, service delivery, and demand generation an
communications. The tool focuses on operational costs and selected capital expenditures.
Estimations are based on typical conditions: As a global/regional cost estimation tool, the
is based on a model of typical service delivery conditions which may not fit all country co
can affect the accuracy of the estimates for any given country.
Disclaimers Outputs are based on users-specified parameters, including unit costs: As a costing model
output are based on population and service delivery parameters, and unit prices for specif
as the vaccine final price, supplies, human resources, etc. End users are expected to edit th
parameters based on their knowledge of local conditions. The final output is also sensitive
editable parameters such as how the target population is defined and quantified, human re
allocated to the vaccination program, and the number and type of health facilities involve
program.
COVID-19 vaccine candidate and other parameters are not final: Due to the rapid introdu
COVID-19 vaccination, key specifications are not finalized and assumptions have to be m
Please review and accept the disclaimer before
A1.2 General Instructions
E-mail Address for Support: CVICosting@who.int
1. Red text font, as used in this sentence, is for important instructions, cautions, and notes.
2. This costing tool requires country-specific inputs. Input cells are color-coded for your convenience and ease of data entry. Inputs ar
Advanced users may customize certain parameters elsewhere, for example in B4.
Inputs which are required for all users are marked with a dark green cell with the number "1". Advanced users who wish to customize
optionally modify inputs associated with a dark brown cell with the number "2" - otherwise, these can can be left at default settings.
1
2
3. Please look for cells with the orange shade - cells of this color are for the user to input data. Some cells require numbers but some re
using a drop down menu.
Enter inputs in cells like this
4. Cells with a green shade provide suggestions and instructions for inputs - either defaults or basic calculations from public databases
Suggestions are in green
5. Pink cells with the word "CHECK" - indicate that there is an error with the input. Please review. Once the input is valid, the cell cha
CHECK
OK
6. Cells which have a grey shade and orange or black text are to display calculations. This is informational only and should not be edit
Calculations only
7. Additional minor clarifications and Notes a

Notes
Further explanation or details
8. A grey navigation bar is provided at the top of each sheet. The navigation bar has orange buttons to help take guide you through the
costing tool. If you are lost at any stage, click "Menu" to take you back to the Quick Links Menu below.
9. As many aspects of Covid-19 vaccination are not finalized, many parameters in this model such as default unit prices, quantities of
be updated even after this tool is deployed. To do so, click "Refresh All" under the menu "Data" above. Please note that a security war
Content". We recommend you make a backup of the completed tool before performing an update.
A1.3 Quick Links Menu

Name of Sheet
Ref (Click to jump to sheet)
A2 INPUT Population & Delivery

A3 INPUT Unit Costs
A4 INPUT Central Costs
B1 Target Population
B2 Vaccines and Supplies
B3 International Logistics
B4 Domestic Logistics
B5 Last Mile Delivery
R1 OUTPUTS
R2 Resource Mapping
T1 Vaccines

Next Item
© World Health Organization and the United Nations Children’s Fund (UNICEF), 2021. Some rights reserved. Th
WHO reference number: WHO/2019-nCoV/Vaccine_deployment_tool/2021.2
  
Next Page Results Help
ction and deployment Costing tool (CVIC Tool) Start Page

‫ | اختيار اللغة‬Language selection | Sélection de la langue | Выбор языка | Selección de idioma | Seleção de idioma | 选择语言
guage, please review all dropdown menu responses to ensure they are answered in the language currently selected
Note: CVIC v2.1 requires Microsoft Excel 2016 (v16.0) or newer Note: CVIC v2.1 require
https://www.who.int/publications/i/item/10665337553
ault unit prices, incl. for vaccine related supplies, are unstable due to market
ne specifications are preliminary and indicative only. SUBJECT TO
Please check and confirm that

you have read, understand, and
accept the disclaimer ↓ Check
vaccination costing estimation tool: The tool is meant to help governments,

akeholders estimate the introductory and deployment cost of COVID-19 vaccine
ice delivery, before detailed planning can take place. These costs include central
al and domestic logistics, service delivery, and demand generation and
tool focuses on operational costs and selected capital expenditures.
on typical conditions: As a global/regional cost estimation tool, the costing model

f typical service delivery conditions which may not fit all country contexts. This
y of the estimates for any given country.
CHECK
users-specified parameters, including unit costs: As a costing model, the final
opulation and service delivery parameters, and unit prices for specific inputs such
ice, supplies, human resources, etc. End users are expected to edit these
heir knowledge of local conditions. The final output is also sensitive to end user
uch as how the target population is defined and quantified, human resources
nation program, and the number and type of health facilities involved in the
andidate and other parameters are not final: Due to the rapid introduction of
on, key specifications are not finalized and assumptions have to be made.
accept the disclaimer before proceeding
uctions, cautions, and notes.
e color-coded for your convenience and ease of data entry. Inputs are required in sheets A2, A3, A4, and B1.
example in B4.
en cell with the number "1". Advanced users who wish to customize certain aspects of the costing model can
e number "2" - otherwise, these can can be left at default settings.
re for the user to input data. Some cells require numbers but some require specific options which can be selected
or inputs - either defaults or basic calculations from public databases and/or other inputed data.
ror with the input. Please review. Once the input is valid, the cell changes color to green and states "OK".
splay calculations. This is informational only and should not be edited.
navigation bar has orange buttons to help take guide you through the completion of the input requires in this
back to the Quick Links Menu below.
ny parameters in this model such as default unit prices, quantities of commodities, and vaccine specifications can
sh All" under the menu "Data" above. Please note that a security warning may be displayed - please "Enable
ol before performing an update.
Description Is user input needed?

Specify country context, target population, delivery parameters, and YES
vaccine supply
Input country-specific units costs for labor, services, and supplies YES
Tabulate country-specific units costs for central-level activities YES
Estimate the target population size, timing of vaccination, and YES
vaccine dose requirements
Estimate the quantity and cost of vaccines and supplies NO
Estimate international shipping, import duties, and handling NO
Estimate cold chain, logistics, and security Optional (for advanced customization)
Estimate last mile service delivery Optional (for advanced customization)
Results of this costing tool NO
A resource mapping tool YES
Update the COVID-19 vaccine specification database Optional (for advanced customization)
ildren’s Fund (UNICEF), 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
ployment_tool/2021.2
de idioma | 选择语言
Note: CVIC v2.1 require

Dedicated to my daughter Xinlin who had to put up with her parent's WFH without childcare
NC-SA 3.0 IGO licence.
NAVIGATION BAR:
A2. Country Context, Target Population, Delivery Parameters, and Vaccine Supply
A2.1 Country Paramenters
Country
1
1
2
Health Financing Context (Informational Only)
Healthcare Infrastructure (FYI Only)
A2.2 Identification of Target Populations for Stages I - III
Total Population
2
2
2
A2.2-1 Health workers | Delivery Modality 1 (Fixed sites with cold storage) - work-based eligibility
2
2
2
1
1
A2.2-2 Essential workers and related groups | Delivery Modality 1 and/or 2 (Fixed 'campaign' sites without col
2
2
2
2
2
2
1
1
A2.2-3 Older adults defined by age-based risk specific to country/region; specific age cut-off to be decided at t
2
2
2
1
1
2
1
2
A2.2-4 Sociodemographic groups at significantly higher risk of severe disease or death | Delivery Modality 1, 2
1
1
1
1
2
1
1
1
1
1
A2.2-5 Groups with comorbidities or health states determined to be at significantly higher risk of severe diseas
1
1
A2.3 Delivery Parameters

Geographic Context (Informational Only)
Human Resources for Health (as potential supply of vaccinators NOT target population)
2
2
2
2
2
2
1
1
1
2
2
1
2
2
Distribution and Service Points
1
1
1
1
1
2
2
2
2
2
2
Logistics and Cold Chain
2
2
2
2
2
2
1
2
A2.4 Vaccine Selection, Wastage, and Expected Uptake

Vaccine Selection for Delivery Modalities
1
1
1
1
Vaccine Wastage (for demand estimations)

1
2
2
2
2
Expected Uptake, by delivery modality and eligibility crriteria. Please consider country-specific factors as uptake rate
1
1
1
1
1
1
A2.6 Vaccine Supply
A2.6.1 Covax Vaccine Supply for 2021 only

COVAX Participation Status
1
1
1
1
1
1
Gavi COVAX Advance Market Commitment (AMC) Countries
Committed Purchase Arrangement (CPA)
Optional Purchase Agreement (OPA)
2
A2.6.2 Non-Covax Vaccine Supply (2021-2023)
1
1
1
1
1
1
1
1
1
1
1
1
A2.6.3 Total Available Vaccine Supply, 2021-2023
   
AVIGATION BAR: Menu Next Page Results Help
2. Country Context, Target Population, Delivery Parameters, and Vaccine Supply
A2.1 Country Paramenters

Instructions: Please select the country and local currency unit to be used from the dropdown list.
Country
Name of Country
What Local Currency Unit (LCU) to use for unit costs?
Currency conversion to use - 1 USD in LCUs (LEAVE BLANK for autocompletion):
WHO Region
World Bank Region
World Bank Lending Category
ADB Regional Member
Health Financing Context (Informational Only)

Current Health Expenditure (current US$)
General Government Health Expenditure (current US$)
Domestic General Government Health Expenditure (current US$)
External Health Expenditure (current US$)
Health Capital Expenditure (current US$)
Healthcare Infrastructure (FYI Only)

Hospitals
Health Centers
Health Posts
A2.2 Identification of Target Populations for Stages I - III

Instructions: Please confirm the total population data or specify the population using national data, if preferred
Total Population
Manually specify total population here OR leave blank to use UN WPP (2019 Revision) Data
2021
2022
2023
A2.2-1 Health workers | Delivery Modality 1 (Fixed sites with cold storage) - work-based eligibility
Instructions: Based on the NDVP/SAGE recommendations, please fill in the total (across all stages I - III) relevant target population, for
section B1.2.
SAGE Population Description
Health workers at high to very high risk of acquiring and transmitting infection
Health workers engaged in immunization delivery (routine programme-specific and COVID-19)
Health workers at low to moderate risk of acquiring and transmitting infection
Total
Instructions: If the total reflects the NDVP intent, please enter it here either as an absolute population count OR as a percent of total popu
THEREFORE, Health workers … as absolute number OR
… as percent
NOTE: This population will be vaccinated at fixed sites with cold storage (Delivery Modality 1)
A2.2-2 Essential workers and related groups | Delivery Modality 1 and/or 2 (Fixed 'campaign' sites without cold storage) - wo
section B1.2.
Note: Please do not double count high-risk age groups here

Personnel needed for vaccine production and other high-risk laboratory staff
High-priority teachers and school staff
Low-priority teachers and school staff
Remaining teachers and school staff.
Other essential workers outside health and education sectors (examples: police officers, municipal services,
child-care providers, agriculture and food workers, transportation workers, government workers essential to
critical functioning of the state not covered by other categories).
Border protection staff screening for imported cases and workers for outbreak management
Essential travellers at risk for acquiring infection outside the home country and reintroducing infection upon
return to home country
All travellers at risk for acquiring infection outside the home country and reintroducing infection upon return
to home country.
Social/employment groups at elevated risk of acquiring and transmitting infection because they are unable to
effectively physically distance
Emergency reserve of vaccines for utilization for outbreak response or mitigation (for example, severe
localized outbreak).
Total
Instructions: If the total reflects the NDVP, please enter it here either as an absolute population count OR as a percent of total population
THEREFORE, Essential workers and related groups … as absolute number OR
… as percent
NOTE: This population will be vaccinated at fixed sites with cold storage (Delivery Modality 1) and during campaigns (Delivery
What percent of the "Essential workers and related groups" live or work near fixed sites with cold storage?
A2.2-3 Older adults defined by age-based risk specific to country/region; specific age cut-off to be decided at the country leve
Instructions: Based on the NDVP/SAGE recommendations, please select the specific age cut-off as decided by the country.
Older adults defined by age-based risk specific to country/region; specific age cut-off to be decided at the
country level
Select age cut-off

Instructions: Please confirm the total high-risk (by age) population data or specify the population using national data, if preferred
Manually specify the older persons population here OR leave blank to use UN WPP (2019 Revision) Data
2021
2022
2023
Instructions: If the country wishes to cover older persons living in residential institutions, please fill below. Else enter 0.
How many (absolute number or percent of older persons) live in residential institutions?
… as absolute number OR
… as percent
One social care staff looks after how many residents?
How many residential Institutions for older adults are there in the country?
Instructions: If the country wishes to vaccinate household members of older adults AND those with underlying health conditions, please
Do you wish to vaccinate household members of older adults AND those with underlying health
conditions (A2.2-5)?
Household Size - FYI only
Additional household members to cover per older adult / person with underlying health conditions
NOTE: Depending on location, older adults will be vaccinated at fixed sites with cold storage (Delivery Modality 1), during camp
Among those living in easier-to-reach communities, what percent of the "Older adults" and other high risk
groups [A2.2-5] live or work near fixed sites with cold storage?
A2.2-4 Sociodemographic groups at significantly higher risk of severe disease or death | Delivery Modality 1, 2, 3, and/or 4 -
percent of total population. Please note that the prioritization of these populations over Stage I-III can be specified later in section B1.2.
Note: Please do not double count high-risk age groups or other priority groups here
Sociodemographic groups at significantly higher risk of severe disease or death (depending on country context,
examples may include: disadvantaged or persecuted ethnic, racial, gender, and religious groups and sexual
minorities; people living with disabilities; people living in extreme poverty, homeless and those living in
informal settlements or urban slums; low-income migrant workers; refugees, internally displaced persons,
asylum seekers, populations in conflict settings or those affected by humanitarian emergencies, vulnerable
migrants in irregular situations; nomadic populations; and hard-to-reach population groups such as those in
rural and remote areas).
For the purposes of costing this diverse population group it is divided into 4 sub-categories, based on delivery modality:
1. Those who live in accessible communities,

vaccinated at fixed sites and during campaigns (Delivery Modality 1 and 2)
… as absolute number OR
… as percent
2. Those who live in residential facilities / refugee camps,

vaccinated at these residential facilities / camps (Delivery Modality 3)
For example: Refugee camps
Residents (not for older adults) … absolute number OR
… as percent
One staff looks after how many residents?
How many such residential facilities / camps (not for older adults) are there in the country?
3 Special populations who are Hard-to-Reach,

who will be vaccinated by outreach (Delivery Modality 4)
For example: Refugees, internally displaced persons, nomadic populations
Hard-to-reach population groups … absolute number OR
… as percent
General hard-to-reach population | Delivery Modality 4 - voluntary eligibility

"Hard-to-reach population groups such as those in rural and remote areas", who will be vaccinated by outreach (Delivery Modality
Special Note: This is a potentially large group of people within the country AND overlaps with other priority populations, i.e. (i) "Older
death".
Please input the TOTAL POPULATION who will need to be reached by outreach, DOUBLE COUNTING overlapping groups such as
or death". Please DO NOT double count special populations who are hard-to reach defined above.
Or, put differently, out of the total of "Older Adults", "Groups with comorbidities or health states determined to be at significantly highe
(Delivery Modality 4)?
Rural population - FYI only

Hard-to-reach population groups … absolute number OR
… as percent
A2.2-5 Groups with comorbidities or health states determined to be at significantly higher risk of severe disease or death | D
Informational demographic and epiemiological data to assist with completing this section
Obesity Prevalence - FYI only
Diabetes Mellitus Prevalence - FYI only
Crude Birth Rate (CBR)
Note: Please do not double count high-risk age groups here
in section B1.2. Helpful data sources are provided on the right.
Groups with comorbidities or health states determined to be at significantly higher risk of severe disease or
death
… absolute number OR
… as percent
Logic checks for target population specifications - no data entry required

Instructions: No data entry is required below but check if there are any errors flagged "CHECK" instead of "OK". If so, please review th
Note: If any logic checks have failed, please re-adjust target population parameters
Additional population check #1: ERROR if target population exceeds total population
Additional population check #2
Additional population check #3
A2.3 Delivery Parameters

Geographic Context (Informational Only)
Surface area
Pacific island small state?
Urban population
Population in the largest city
Fragile and conflict affected situation?
Instructions: Please specify the core HRH cadres who may be considered as POTENTIAL supply of vaccinators. Please note that the mo
contextualized against the POTENTIAL supply of vaccinators. Additional user defined HRH cadres can be specified. OR a grand total m
estimates of National Health Workforce Accounts will be used.
Note: This version of the model estimates needs for a single cadre of vaccinators. Supervisors and others are not included in this version
Human Resources for Health (as potential supply of vaccinators NOT target population)
Medical Doctors
Nurses
Midwives
Pharmacists
(User defined HRH who can be vaccinator)
(User defined HRH who can be vaccinator)
Total HRH Supply for Potential Vaccinator Impact
[override here to provide an overall number]
Maximum redeployable HRH, % of health workforce … as absolute number OR

… as percent
Working Hours per Day

Working Days per Week
Mobile Team Travel and Setup Time (Hours) per Working Day
HRH robustness adjustments (to define upper and lower variant)
For domestic personnel transport: Maximum capacity per car
Distribution and Service Points

Instructions: Please indicate the total number distribution points and service points nationwide which will be used for Covid-19 vaccinat
Number of sub-national level 1 admin. divisions (e.g. province/region/state) - cold-storage distribution points
Number of sub-national level 2 admin. divisions (e.g. district) - cold storage distribution points
Fixed sites with cold-storage
Campaign sites (Fixed sites without cold-storage)
Outreach sites
What percent of the hard-to-reach population vaccinated by outreach:

… need to be reached by mobile team Type A (single-person team)
… need to be reached by mobile team Type B (multi-person team)
… [implied remainder] can come to the outreach site ('the basecamp')
For vaccinations during campaigns and at residential institutions:

… percent which originate from fixed sites
… percent which originate from district-level stores
… [implied remainder] percent which originate from regional-level stores
For vaccination by outreach:

… percent which originate from fixed sites
… percent which originate from district-level stores
… [implied remainder] percent which originate from regional-level stores
Logistics and Cold Chain

One time period, in days, is
Combine international shipments?
Vaccination Secondary Packaging Volume Buffer
International shipments per period
Vaccination deliveries from central to regional per period
Vaccination deliveries from regional to district + health facilities per period
Cold-storage reserve capacity
Solar Direct Drive cold storage (versus on-grid electricity)
Use Long Range (4 days cold like) cold boxes for outreach?
A2.4 Vaccine Selection, Wastage, and Expected Uptake

Vaccine Selection for Delivery Modalities
Instructions: Please select the vaccine type to be used for costing. You may select separate vaccine types for each delivery modality. You
one or more or all delivery modalities.
Delivery Modality 1: Fixed sites with cold-storage

Delivery Modality 2: Campaigns at fixed sites with no cold-storage
Delivery Modality 3: Residential Institutions
Delivery Modality 4: Outreach & Mobile sites
Click here to change vaccine specifications
Vaccine Wastage (for demand estimations)
Default Vaccine Wastage Rate
Default Wastage Multiplication Factor (WMF)
Vaccine Wastage Rate - for Delivery Modality:

1 - ChAdOx1-S (COVISHIELD)
Expected Uptake, by delivery modality and eligibility crriteria. Please consider country-specific factors as uptake rates may vary wid
Work-based | Delivery Modality 1
Voluntary | Delivery Modality 1
Work-based | Delivery Modality 2
Voluntary | Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
A2.6 Vaccine Supply
A2.6.1 Covax Vaccine Supply for 2021 only

COVAX Participation Status
GAVI 56 Status
Advance Market Commitment (AMC) country?
If not AMC, Committed or Optional Purchase Agreement?
Covax Request or, when confirmed, Allocation

Instructions: For Covax participants (AMC92 or self-financing), please enter the Covax vaccine supply request, OR once allocations are
of a number of doses rather than population coverage, a simple calculator is provided below to assist with the conversion.
For AMC92 countries, if supply requests above the fully-subsidized amount are desired based on cost-sharing arrangements, please ente
IMPORTANT NOTE: Actual number of fully-subsidized vaccine doses which can be supplied by COVAX will depend on vaccin
supply, and available resources, and may be higher or lower than numbers listed here
Stage 1 (H1 2021)

Stage 2 (H2 2021)
H1 2022
H2 2022
H1 2023
H2 2023
To convert number of doses to percent of total population in 2020, excluding wastage, use this simple calculator:
Number of doses per course
Number of doses
as 'percent of total population in 2020':
Gavi COVAX Advance Market Commitment (AMC) Countries

Fully-subsidized doses (2021)
Cost-sharing doses (orders above fully-subsidized doses; 2021)
Implied Covax subsidy (covered by Covax for AMC countries)
Cost-sharing fully-loaded price per dose
Cost-sharing for additional doses
Committed Purchase Arrangement (CPA)

Upfront payment per dose
Financial guarantee
Final price upper limit
Final price
Total upfront payment
Total financial guarantee
Maximum final price (excluding up-front and financial guarantee)
Total, based on final price
Remainder
Optional Purchase Agreement (OPA)

Upfront payment per dose
Risk-sharing gurantee
Final price
Total upfront payment
Total risk-sharing gurantee
Total, based on final price
Remainder
A2.6.2 Non-Covax Vaccine Supply (2021-2023)

Instructions: Use this section for vaccine dose supply obtained beyond Covax - including domestic production, in kind donations,
Non-Covax vaccine doses (courses as percent of 2020 population)
Stage 1 (H1 2021)
Stage 2 (H2 2021)
H1 2022
H2 2022
H1 2023
H2 2023
Total cost of the non-Covax vaccine doses, USD

Stage 1 (H1 2021)
Stage 2 (H2 2021)
H1 2022
H2 2022
H1 2023
H2 2023
A2.6.3 Total Available Vaccine Supply, 2021-2023

Total Covid-19 vaccine doses as percent of 2020 population
Stage 1 (H1 2021)
Stage 2 (H2 2021)
H1 2022
H2 2022
H1 2023
H2 2023
World Health Organization and the United Nations Children’s Fund (UNICEF), 2021. Some rights reserved. This work is ava
HO reference number: WHO/2019-nCoV/Vaccine_deployment_tool/2021.2

Help
Input Here
INPUTS Suggestion Derived
CHECK #N/A
CHECK #N/A
#N/A OK #N/A
#N/A
#N/A
#N/A
NO
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
INPUTS Suggestion
if preferred
Leave Blank OK #N/A

Leave Blank OK #N/A
Leave Blank OK #N/A
I - III) relevant target population, for each population described. Please note that the prioritization of these populations over Stage I-III can be specifie
EXCLUDE Social care workers in residential institutions (see A2.2-3)
0 Note: Prioritization / sequencing is specified in B1.2
on count OR as a percent of total population

CHECK #N/A
} OR
} OR
#N/A #N/A
Note: If BOTH absolute number AND percent are completed, percent will be used
n' sites without cold storage) - work-based eligibility

I - III) relevant target population, for each population described. Please note that the prioritization of these populations over Stage I-III can be specifie
EXCLUDE Residential institutions (see A2-2-4)
- Note: Prioritization / sequencing is specified in B1.2
nt OR as a percent of total population

CHECK #N/A
} OR
#N/A #N/A
Note: If BOTH absolute number AND percent are completed, percent will be used
1) and during campaigns (Delivery Modality 2)
50% OK
to be decided at the country level | Delivery Modality 1, 2, 3 (Residential Institutions), and/or 4 (Multi-day outreach) - voluntary eli
decided by the country.
65 CHECK #N/A
sing national data, if preferred
n) Data
Leave Blank OK #N/A
Leave Blank OK #N/A
Leave Blank OK #N/A
l below. Else enter 0.
OK #N/A
} OR
0.0% OK 0.00%
3 OK
00 OK 0
underlying health conditions, please fill below. Else enter 0.

---
0 OK
(Delivery Modality 1), during campaigns (Delivery Modality 2), at residential institutions (Delivery Modality 3), or by outreach (Delivery Mo
OK
50%
very Modality 1, 2, 3, and/or 4 - voluntary eligibility

I - III) relevant target population, for the populations described, broken down by the vaccination delivery strategy - either as an absolute population co
an be specified later in section B1.2.
ased on delivery modality:
CHECK #N/A
} OR
#N/A #N/A
EXCLUDE Older adults (see A2.2-3)

CHECK #N/A
} OR
#N/A #N/A
5 OK
#N/A #N/A #N/A
NOTE: Please do not double count the general hard-to-reach population ("Hard-to-reach population groups such as those in rur
CHECK #N/A
} OR
#N/A #N/A
ated by outreach (Delivery Modality 4). See Special Note.

er priority populations, i.e. (i) "Older Adults" and (ii) "Groups with comorbidities or health states determined to be at significantly higher risk of sever
UNTING overlapping groups such as "Older Adults" and "Groups with comorbidities or health states determined to be at significantly higher risk of se
determined to be at significantly higher risk of severe disease or death", and non-prioritized groups, what proportion will need to be vaccinated by outr
#N/A
CHECK #N/A
} OR
#N/A #N/A
sk of severe disease or death | Delivery Modality 1, 2, 3, and/or 4 - voluntary eligibility

#N/A
#N/A
#N/A
I - III) relevant target population, for the population described below. Please note that the prioritization of these populations over Stage I-III can be sp
https://www.who.int/data/gho http://www.healthdata.org/gbd/2019
EXCLUDE Older adults (see A2.2-3) and pregnant women

CHECK #N/A
} OR
#N/A #N/A
stead of "OK". If so, please review the target population specifications and/or timing of delivery (B1.2)
#N/A
#N/A
OK
Leave Blank #N/A

#N/A #N/A #N/A
#N/A
#N/A
#N/A #N/A #N/A
f vaccinators. Please note that the model separately estimates vaccinators required and this section is to allow the required vaccinator workforce to be
s can be specified. OR a grand total may be specified instead to override the sum total of the individual carders. If this section is left blank, data from
others are not included in this version.
Leave Blank #N/A

Leave Blank #N/A
Leave Blank #N/A
Leave Blank #N/A
Leave Blank -
Leave Blank -
#N/A
Leave Blank #N/A
Leave Blank OK #N/A

Leave Blank OK #N/A
8 8 OK
4.5 4.5 OK
CHECK
2.5 2.5 OK
3 3 OK
ch will be used for Covid-19 vaccination, as per the description below:

CHECK
CHECK
CHECK
#N/A #N/A
#N/A #N/A
20% OK
30% OK
OK 50%
30% OK
40% OK
OK 30%
30% OK
40% OK
OK 30%
180 180
Yes Yes OK
1.25 1.25 OK
2 2 OK
2 2 OK
2 2 OK
1.25 1.25 OK
CHECK
Yes Yes OK 4
types for each delivery modality. You may also use the same vaccine for
Doses per course

ChAdOx1-S (COVISHIELD) OK 2
ChAdOx1-S (COVISHIEL OK 2
CHECK
1.000
If wish to override default, else leave blank WMF

1.000
1.000
1.000
1.000
ctors as uptake rates may vary widely by country. 100% = all those eligible for vaccination will accept vaccination.
CHECK
CHECK
CHECK
CHECK
CHECK
CHECK
NO
NO
Committed OK Committed
pply request, OR once allocations are confirmed, update this section with the confirmed allocation by half-year time periods. If the allocation is presen
st with the conversion.
ost-sharing arrangements, please enter these the excess above the full-subsidized amount in 2022 onwards.
d by COVAX will depend on vaccine prices, characteristics,
3.00% 3.0%
17.00% 17.0%
0.0%
0.0%
0.0%
0.0%
ple calculator:
2
#N/A
#N/A
0.0%
0.0%
$ -
Leave Blank $ 7.00
$ -
$ 1.60
$ 8.95
$ 21.10
Leave Blank $ 7.00
#N/A
#N/A
#N/A
#N/A
#N/A #N/A
$ 3.10
$ 0.40
Leave Blank $ 7.00
$ -
$ -
$ -
OK $ -
production, in kind donations,

Courses
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
Percent of total population in 2020 Courses

3.00% #N/A
17.00% #N/A
0.00% #N/A
0.00% #N/A
0.00% #N/A
0.00% #N/A

Next Item
ights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
Logic checks failed - Errors = 22
Unit / Comment
LCUs | Last auto update: 2021-04-23
1 = Yes
che_usd
gghe_usd
gghed_usd
ext_usd
hk_usd
Unit / Comment
Number
Number
Number
these populations over Stage I-III can be specified later in
ns (see A2.2-3)
Whole number
Percent of Total Population
these populations over Stage I-III can be specified later in
Whole number
Percent of the Target Group
nd/or 4 (Multi-day outreach) - voluntary eligibility
Years | Percent of Total Population
Number
Number
Number
Whole number
Percent of High-Risk (by Age) Population
One staff for every n residents.
Whole number
Average household size (number of members)
Number, can be decimal; Zero is allowed
very Modality 3), or by outreach (Delivery Modality 4)
Percent of the Target Group
very strategy - either as an absolute population count OR as a
Whole number
Whole number
One staff for every n residents
Whole number
o-reach population groups such as those in rural and remote areas") described next
ermined to be at significantly higher risk of severe disease or
determined to be at significantly higher risk of severe disease
hat proportion will need to be vaccinated by outreach

Percent of those Age 18+
Percent of those Age 20-79
per 1,000
on of these populations over Stage I-III can be specified later
Percent of Low-Risk (by Age) Population
2)
Unit / Comment
Sq km
1 = Yes | 0 = No
Percent of total population
Percent of urban population
1 = Yes | 0 = No
to allow the required vaccinator workforce to be
al carders. If this section is left blank, data from the latest
Percent of Total HRH Supply

Percent of health workforce
hours
days
hours
mins
Whole number; Non-zero

Whole number
Whole number
Percent of Difficult to Access Population

Days
Blank assumed as NO
Factor (i.e. 1.25 = 25% extra)
Whole number; Time period is half a year
Factor (i.e. 1.25 = 25% extra)
Proportion of total cold storage
Unit / Comment
accept vaccination.
Percent of those offered COVID-19 vaccination
Unit / Comment
half-year time periods. If the allocation is presented in terms
wards.
Percent of total population in 2020


USD
USD per dose
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Comments
Leave blank for auto completion; Source: http://www.floatrates.com/daily/usd.xml . To update - go to Data | Refresh All
This is used in Sheet R2 for health financing benchmarking

Source: WHO Global Health Expenditure Database (GHED) Preliminary Data for 2018
Source: GHO | DEVICES00 |Total density per 100 000 population: Hospitals | Assume cold-storage
Source: GHO |DEVICES02 | Total density per 100 000 population: Health centres | Assume cold-storage
Source: GHO | DEVICES01 | Total density per 100 000 population: Health posts | Assume NO cold-storage
Comments
Source: UN WPP 2019

Source: UN WPP 2019
Source: UN WPP 2019
EXCLUDE Social care workers in residential institutions; Max 10%
EXCLUDE wardens / staff at residential institutions

Max 20%
Or, put differently, what proportion of this target population is to be reached by Delivery Modality 1. 0% = All DM2; 100% = All DM1
Source: UN WPP 2019

Source: UN WPP 2019
Source: UN WPP 2019
Delivery Modality 3
e.g. nursing homes; assumes this sub-population is immobile
Max 10%;
Derive the number of social care workers from this - will be vaccinated together with residents; Enter zero if not covering this group.
Source: https://population.un.org/Household/index.html | United Nations, Department of Economic and Social Affairs, Population Division (2019). Database on Househo
How many additional household members to vaccinate for each priority individual with underlying health conditions or above HR age threshold. Enter zero if not coverin
Delivery Modality 1 vs 2. Note: For older adults reached by Delivery Modality 4, please see [A2.2-4 Question 4]
Max 10%
Assumes this sub-population is immobile

Max 10%
Derive the number of staff from this - will be vaccinated together with residents; Zero if not covering this group
l and remote areas") described next
Max 10%; Note: Will use the same DM1 to DM2 proportion as A2.2-3
Source: WDI
Max 90%; If using a high value, please ensure that the target population defined does not exceed the total population
FYI only; Source: GHO - Prevalence of obesity among adults, BMI >= 30 (crude estimate) (%)
FYI only; Source: WDI SH.STA.DIAB.ZS | Diabetes prevalence (% of population ages 20 to 79)
Source: SP.DYN.CBRT.IN | https://data.worldbank.org/indicator/SP.DYN.CBRT.IN
Max 50%
A "CHECK" error here means that the high-priority population specified exceeds the total population
If any error here - please adjust the timing in B1.2 for residential institutions for high risk age groups - do not spread out the delivery thinly
If any error here - please adjust the timing in B1.2 for residential institutions for low risk age groups - do not spread out the delivery thinly
Comments
Source: WDI
IF PIC, consider a universal immunization strategy
Source: WDI SP.URB.TOTL.IN.ZS
Source: WDI
Security costs will be activated by default. Can be overriden in Sheet A3.
Source: WHO estimation of stock in 2020 based on latest reported health workforce stock in the National Health Workforce Accounts
Countries can add additional cadres if needed for HRH supply - pool of potential vaccinators - NOTE THIS IS NOT health workers to be vaccinated
Countries can add additional cadres if needed for HRH supply - pool of potential vaccinators - NOTE THIS IS NOT health workers to be vaccinated
If no data or data from GHO not updated, MUST override here. Leave blank to use NHWA data
Vaccinators may be (i) redeployed health workers or (ii) newly recruited health workers. This model estimates vaccinator human resource needs. If these exceed the maxi
The redeployment factor is the percentage of the current health workforce that can be redeployed to conduct vaccination (WHO estimate). It varies by country and consid
Entering 100% means that all vaccinators will be redeployed health workers. Unlike newly recruited vaccinators, salaries for redeployed health workers are not included
Consider time needed for training, supervision, and breaks

Will be subtracted from working hours per day - remaining hours will be uninterupted vaccination unless no more
persons to vaccinate
Minutes of health worker time required to vaccinate per dose - added (upeer variant) or subtracted (lower variant) to medium variant in T1 vaccines database
Consider space needed for cold boxes and dry storage
"Regions" in this model: (i) regional cold storage distribution points; (ii) potential origins for outreach and campaigns
"Districts" in this model: (i) district-level cold storage distribution points, (ii) potential origins for outreach and campaigns
Delivery Modality 1 (e.g. appointments, group schedules)
Delivery Modality 2 (e.g. one-day campaigns); Avoid using too few sites (e.g., not less than half the number of fixed sites with cold storage)
Delivery Modality 4 (e.g., outreach) | Population centers | EPI sites for remote populations)
Delivery Modality 4 (e.g., outreach / mobile)

Delivery Modality 4 (e.g., outreach / mobile)
Delivery Modality 4 (e.g., outreach)
This is for estimation of cold storage capacity needs at the various levels
This is for estimation of cold storage capacity needs at the various levels
Changes not allowed

If different vaccines have the same temperature requirements, pack and ship together
Source: WHO WHO/IVB/08.01 2008 pg 24
From manufacturer country to receiving country point of entry
Reserve capacity needed at all levels of cold storage

This is for cold storage at fixed sites and districts..Central and regional cold storage assummed to be on-grid
Default is long range. "No" = Short Range (2 days); Source: https://www.unicef.org/supply/media/4411/file/E004-cold-boxes-vaccine-carriers%20-procurement-guidelin
Comments
Suggest to prefer a vaccine with the least stringent requirements for this modality. AVOID UCC vaccines for DM4 (Outreach) as costs assumptions may not be valid.
Note: Covax supply allocations do not calculate in vaccine wastages
Source for formula - WHO WHO/IVB/08.01 2008
This section allows the user to input delivery modality specific vaccine waste rates IF DESIRED, leave blank otherwise
Expected vaccine acceptance by delivery modality and target group (work-based eligibility criteria vs voluntary)
Note: Expected uptake for vaccination by individuals eligible by virtue of their occupation ('work-based') may be higher than those who are invited for vaccination due to
Further reading
Lazarus, J.V., Ratzan, S.C., Palayew, A. et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 27, 225–228 (2021). https://doi.org/10.1038/s415
Comments
1 = Yes
1 = Yes
Options: Committed | Optional | Non-participant; Ignored if AMC
Covax available supply in Stage 1 (H1 2021); Max 20%

Covax available supply in Stage 2 (H2 2021)
Covax available supply; Overall total can exceed 100% of total population
Note: Total population in 2020 for Covax calculations is based on World Bank projections for 2020
For costing vaccine doses which are supplied by Covax, a 1-dose course vaccine (e.g. JNJ-78436735) will use the same average price per course as a 2-dose course vacc
Price for additional (cost sharing) doses; Leave blank to use default (Covax estimated fully-loaded average price)
For costing vaccine doses which are supplied by Covax, a 1-dose course vaccine (e.g. JNJ-78436735) will use the same average price per course as a 2-dose course vacc
Note: Quantity of vaccine doses dependent on available Covax supply

Source: COVAX
Source: COVAX
If final price above this, CPA participant can cancel
Final price for CPA doses; Leave blank to use default
Assumes a 2-dose regiment; Based on requested quantity
Assumes a 2-dose regiment; Based on requested quantity
Assumes a 2-dose regiment; Based on available quantity

Total (based on final price) minus upfront payment; Warning if negative number
Source: COVAX
Source: COVAX
Assumes a 2-dose regiment; Based on requested quantity; Paid on signing agreement

Assumes a 2-dose regiment; Based on requested quantity; To be paid by Oct 9, 2020
Total (based on final price) minus upfront payment and risk-sharing guarantee; Warning if negative number
Allowed to exceed 100% (e.g. if vaccine durability requires multiple courses per person)
Total for all doses in the time period, not per dose
User Notes
User Notes
= All DM2; 100% = All DM1
o if not covering this group.

Social Affairs, Population Division (2019). Database on Household Size and Composition 2019.
h conditions or above HR age threshold. Enter zero if not covering household members.
o not spread out the delivery thinly
not spread out the delivery thinly
User Notes
Health Workforce Accounts

HIS IS NOT health workers to be vaccinated
HIS IS NOT health workers to be vaccinated
mates vaccinator human resource needs. If these exceed the maximum redeployable numbers, additional vaccinators are assu
duct vaccination (WHO estimate). It varies by country and considers the most recently reported UHC index and health workfo
cinators, salaries for redeployed health workers are not included in the costs.
r variant) to medium variant in T1 vaccines database
ch and campaigns
ber of fixed sites with cold storage)
ile/E004-cold-boxes-vaccine-carriers%20-procurement-guidelines.pdf
User Notes
for DM4 (Outreach) as costs assumptions may not be valid.
may be higher than those who are invited for vaccination due to their age, comorbidites, or health states ('voluntary')
ccine. Nat Med 27, 225–228 (2021). https://doi.org/10.1038/s41591-020-1124-9

User Notes
ll use the same average price per course as a 2-dose course vaccine. Vaccine delivery costs will differ.
ll use the same average price per course as a 2-dose course vaccine. Vaccine delivery costs will differ.
  
NAVIGATION BAR: Menu Next Page Results
A3. Unit costs Local Currency Unit (L

General Instructions:: Please use this section to input country-specific unit costs. Unit costs can be inputed as LCUs (in the curr
USD [Column F]. Column F takes precedence if values are inputed in both currencies. Some names [Column C] for items can a
more customization.
For many items, default prices can be used. Default prices may be updated by the costing team from time to time - to do so, und
A3.1 Human Resources for Health

Instructions: Vaccinator compensation is a large cost driver - please complete this section carefully.
Supplementary wages (such as per diems) can be computed either as a daily rate.
In some contexts, it may be desireable to consider regular salaries for vaccinators - for example, if vaccinators are newly recrui
this is not desired, please input 0 under the salary. Leaving this blank will result in a default value being used.
Vaccinator Compensation
1 Supplementary wages / per diems (Daily Rate)
2 Pay per diems for Delivery Modality 1?
Monthly salaries for newly recruited vaccinators [Leave blank to use Enter 0 to exclude
1 default data] salaries from costs
Instructions: Training and deployment costs can be specified at the local (service point) level here and/or can be specified under
level training, recruitment, credentialing, and other costs such as uniforms other items required by each vaccinator. If the trainin
through a digital learning mechanism - and does not involve the local level, cost training from a central level (A4.1-F)
Non-wage costs Per Unique Vaccinator (Local Training and Deployment)

1
2
2
2
Other non-wage costs per Vaccinator per Day (Mobile Teams)

1
2
2
A3.2 Vaccine-related supplies, incl. freight Customs?

Notes: The unit prices of vaccine-related supplies are overridden here. You may leave this section blank to will default to auto-u
Electronic records: Depending on the system used / procured, the costs can be included here (as a per dose unit cost) and/or in A
Are these supplies

subject to customs
clearance?
2 0 Low Dead Space Syringe (0.3ml) AD No
2 1 Syringe (0.5ml) AD No
2 2 23G needle No
2 3 Alcohol Swab, Plaster, Dry Swabs No
2 4 21G needle No
2 5 Sodium Chloride 0.9 % ampule 10mls No
2 6 RUP syringe (3ml) No
2 7 … No
2 8 … No
2 9 Sharps Disposal (5L) No
2 10 Vaccination Card No
1 11 Electronic Records
A3.3 PPEs Quantity

Notes: The type of PPEs, quantities required, and unit costs of PPEs may be reviewed and overridden here. You may leave this
PPE per HRH per Day Leave these cells blank to use default unit costs and
2 Medical mask
2 Alcohol-based hand rub (1L)
2 Liquid soap and water
2 …
2 …
2 …
2 …
2 …
2
2
2
2
2
PPE per Unique HRH Leave these cells blank to use default unit costs and
2 Eye protection
2 Face shield
2 …
2 …
2 …
2
2
2
2
2
A3.4 Logistics Units

Instructions: Please review the unit cost assumptions for freight and related costs.
If the country will be imposing custom clearance duties or tarfiffs for the vaccine doses or vaccine-related supplies, enter it here
International Logistics
1 Airfreight price - First 100kg Per kg
1 Airfreight price - Above 100kg Per kg
1 Ground handling costs per shipment Per shipment
2 Electronic temperature monitoring device (leave blank for default cost) Per container
Vaccinator transport to service point (Delivery Modality 2, 3, and 4)
1 Personnel transport Per km
Instructions: Please include unit costs for transport and other related expenses for outreach teams
Vaccinator last-mile transport for outreach beyond basecamp (Delivery Modality 4)
Mobile Team A (Solo) Per Team per Day
1
2
2
Mobile Team B (Multi-person) Per Team per Day

1
2
2
A3.5 Cold storage and cold chain Customs?

Instructions: Please review the unit cost assumptions for electricity and cold chain transportation. Note that default costs for col
section blank.
If customs clearance will be required for cold-chain supplies, please indicate YES in the appropriate cell.
Power
2 Electricity (per kWh)
Are these supplies
subject to customs
Cold chain supplies clearance?
2 Large, long range, cold box (20L) No
2 Vaccine carrier (1.5L) No
2 Icepacks No
From Central to Regional - calculated based on PER TRIP basis PLUS PER LITER basis
a. Cold-chain logistics and domestic transport, PER TRIP
1 Refrigerated (2 to 8C) per trip
1 Frozen (-20C) per trip
1 Ultra-cold (-60 to -80C) per trip
b. Cold-chain logistics and domestic transport, PER LITER (e.g., to cover additional cold storage requirements)
1 Refrigerated (2 to 8C) per liter
1 Frozen (-20C) per liter
2 Ultra-cold (-60 to -80C) per liter
From Regional to Districts and Fixed Sites - calculated based on PER TRIP basis PLUS PER LITER basis
a. Cold-chain logistics and domestic transport, PER TRIP
1 Refrigerated (2 to 8C) per trip
1 Frozen (-20C) per trip
Ultra-cold (-60 to -80C) per trip
b. Cold-chain logistics and domestic transport, PER LITER (to cover additional cold storage requirements)
1 Refrigerated (2 to 8C) per liter
1 Frozen (-20C) per liter
Ultra-cold (-60 to -80C) per liter
A3.6 Local Data Management and Monitoring, Pharmacovigilance

Instructions: Please add unit costs for local data management. Once-off costs per fixed site or team (e.g. IT equipment, installat
charges and consumables.
Per Fixed Site (DM1) or Per Team (DM2,3,4)

1
2
2
Per Site per Day

1
2
2
A3.7 Local Demand Generation and Communications

Instructions: Please add demand generation and communications units costs per site and per eligible person. This can be a large
carefully. Separate demand generation costs can be used for those who are eligible due to the nature of their work and for those
(voluntary).
Per Site
1
2
2
PER PERSON Eligible for Vaccination (Work-based)

1
2
2
PER PERSON Eligible for Vaccination (Voluntary)

1
2
2
A3.8 Security
Note: By default, security costs are added ONLY for Fragile and Conflict-Affected Situations, but these settings can be overridd
2 OVERRIDE HERE. Do you wish to include security costs? -->
Cells below will be darkened if security cost settings are disabled
2 Security during transport per trip
2 Central store security factor (cost relative to security at fixed sites) factor
Security per Fixed Site per Day
2
2
Security per Mobile Team per Day
2
2
A3.9 Additional Interventions

Note: If no additional interventions are desired, just input 0 under the unit costs
Per Site
2
2
2
Per Vaccinated Person Per Dose
2
2
2
 
Results Help
Local Currency Unit (LCU) selected for unit costs =

nit costs can be inputed as LCUs (in the currency selected in A1.1) [Column E] or in
ies. Some names [Column C] for items can also be edited by the end-user to allow for
osting team from time to time - to do so, under the menu "Data", click "Refresh All".
Change the LCU used by clicking here

LCU: Override in USD USD
section carefully.
- for example, if vaccinators are newly recruited and inducted into the health workforce. If
a default value being used.
CHECK #N/A
Yes OK 1
Yes OK 1
Yes OK 1
Yes OK 1
#N/A
oint) level here and/or can be specified under central costs. This can be used for local
ms required by each vaccinator. If the training program is delivered centrally - e.g.
aining from a central level (A4.1-F)
#N/A
CHECK
#N/A
CHECK

ave this section blank to will default to auto-updateable parameters.
uded here (as a per dose unit cost) and/or in A3.6 (per site/team and/or per site-day)
Leave these cells blank to use default unit

costs
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
CHECK #N/A

wed and overridden here. You may leave this section blank to will default to auto-updateable parameters.
these cells blank to use default unit costs and quantities #VALUE!
2 #N/A
### #N/A
### #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
these cells blank to use default unit costs and quantities #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
0 #N/A
oses or vaccine-related supplies, enter it here.

$ 10.00 OK $ 10.00
$ 6.00 OK $ 6.00
$ 200.00 OK $ 200.00
$ 40.00
$ 0.50 OK $ 0.50
utreach teams
#N/A
CHECK #N/A
#N/A
#N/A
#N/A
CHECK #N/A
#N/A
#N/A

transportation. Note that default costs for cold-chain supplies can be used by leaving that
n the appropriate cell.
$ 0.20 OK $ 0.20
OK #VALUE!
OK $ 49.00
OK #VALUE!
CHECK #N/A
CHECK #N/A
CHECK #N/A
ditional cold storage requirements)

CHECK #N/A
CHECK #N/A
$ 8.60 OK $ 8.60
PLUS PER LITER basis
CHECK #N/A
CHECK #N/A
0.00 $ - $ -
nal cold storage requirements)

CHECK #N/A
CHECK #N/A
0.00 $ - $ -

xed site or team (e.g. IT equipment, installation, etc.) and recurrent costs such as data
#N/A
CHECK #N/A
#N/A
#N/A
#N/A
CHECK #N/A
#N/A
#N/A

e and per eligible person. This can be a large driver of costs - please complete these
due to the nature of their work and for those who are eligible due to non-work criteria
#N/A
CHECK #N/A
#N/A
#N/A
#N/A
CHECK #N/A
#N/A
#N/A
#N/A
CHECK #N/A
#N/A
#N/A

Situations, but these settings can be overridden.
#N/A
0.00 OK #N/A
5 OK #N/A
#N/A
#N/A
0.00 OK #N/A
#N/A
#N/A
#N/A
0.00 OK #N/A
#N/A
#N/A
0.00 OK #N/A
#N/A
#N/A
0.00 OK #N/A
#N/A

Next Item
CEF), 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
.2
#N/A
Comments
This is intended to be marginal costs (per diems, hazard pay, etc.) not baseline salary
Zero is allowed
Default is Yes
Default is Yes
Default is Yes
Default is Yes
Zero is allowed. These are for non-redeployed HRH. Source: Serje, Juliana, Melanie Y. Bertram, Callum Brindley, and Jeremy A. Lauer. 2018. “Global Health Worker
e.g., once-off non-wage expenses for each recruited vaccinator, such as training, recruitment, uniforms, etc.
Training of vaccinators at the local level (within a facility). Training delivered from central [Ref A4.1] EXCLUDED.
e.g., food rations, accomodation, and other expenses. For DM4 (Outreach) only.
Comments
Click here to change or view vaccine specifications @ T1. Vaccines
This allows costing per dose for electronic vaccination and related records. These can also be costed per site / per team and per site-day.
Comments
uto-updateable parameters.
Assume that these can be re-sanitized / re-used. Quantities per duration of the whole program (3-years)
Comments
Basic model: Assumes transport from manufacturer airport until arrival at ONE central store/warehouse in recipient country
https://www.who.int/immunization_standards/vaccine_quality/Vaccines_Shipping_Guidelines082019.pdf
Fuel / fare per km (sharing a car)
If multiple modes of transport - use a weighted average

Say TCO for a motorbike per day, incl. fuel

Say TCO for a 4WD per day, incl. fuel
Comments
Leave blank to use default prices. e.g., E004/036 | https://supply.unicef.org/s0002363.html

Leave blank to use default prices. e.g. PQS E004/050 | https://supply.unicef.org/s0002475.html
Leave blank to use default prices. e.g., https://supply.unicef.org/s0002221.html
Operational expenditures (e.g. rental temperature controlled vehicles, cold chain logistics charges)
Assumption for US$ 8.60 per liter: 25 L disposable dry ice shipper ($100) + 7.2kg locally-sourced dry ice per shipper ($5 per kg of dry ice). Source: Coupa
Costing model would assume 2-8C below regional level - as per 5 days stability for BNT162b2
Costing model would assume 2-8C below regional level - as per 5 days stability for BNT162b2
Comments
Will be counted as capital expenditures
Will be counted as operational expenditures
Comments
All types of services points
Work-based … i.e. a 'captive' audience
Voluntary … i.e., needs to be convinced and persuaded
Comments
If blank, security costs will be added only for FCAS countries
Ignored if not FCAS or security cost settings overridden

Presumably this will be outsourced and paid as an all inclusive charge
Presumably this will be outsourced and paid as an all inclusive charge
Comments
e.g blood pressure machine, capillary blood glucose meter, etc.

e.g., dipsticks, glucostix, etc.
the CC BY-NC-SA 3.0 IGO licence.

User Notes
USD
, Melanie Y. Bertram, Callum Brindley, and Jeremy A. Lauer. 2018. “Global Health Worker
#N/A
ning, recruitment, uniforms, etc.

red from central [Ref A4.1] EXCLUDED.
User Notes Auto-updated default

Covax
fully-
loaded?
USD
#VALUE! 1
#VALUE! 1
#VALUE! 1
#VALUE! 0
#VALUE! 1
#VALUE! 1
#VALUE! 1
#VALUE! 0
#VALUE! 0
#VALUE! 1
#VALUE!
These can also be costed per site / per team and per site-day.

USD Quantity
#VALUE! 2
#VALUE! #VALUE!
#VALUE! #VALUE!
$ - 0
$ - 0
$ - 0
$ - 0
$ - 0
Custom PPEs
he whole program (3-years)

$ 5.00 0
$ 5.00 0
$ - 0
$ - 0
$ - 0
Custom PPEs
USD
ONE central store/warehouse in recipient country
pping_Guidelines082019.pdf $ 40.00
For example, transportation costs such as fuel
For example, transportation costs such as fuel
USD
#VALUE!
.org/s0002475.html $ 49.00
#VALUE!
chain logistics charges)
+ 7.2kg locally-sourced dry ice per shipper ($5 per kg of dry ice). Source: Coupa
ility for BNT162b2
ility for BNT162b2
User Notes
For example, IT infrastructure
For example, telecommunications / data charges, stationary, etc.
User Notes
For example, banners, buntings, posters, sign posting, social distancing measures, local demand generation and communications initiatives
For example, registration and electronic appointment notifications
For example, registration and electronic appointment notifications, demand generation
User Notes
Security Personnel
Security Personnel
User Notes
Item A
Item B
Item C
Item A
Item B
Item C
  
A4. Central-level Costs
A4.1 Central-level costs based on WHO-UNICEF-WB VIRAT-VRAF 2.0 (2 December 2020) + NDVP activi
Item
General Instructions:The purpose of this section is to assist countries to tabulate and consider
central costs for activities specified in the VIRAT-VRAF and NDVP, based on their best
assumptions for reasonable costs for technical assistance (TA), training, supervision, gap analyses,
surveys. The reference to each VIRAT-VRAF 2.0 is provided in column L and can be used if
further clarification is needed on each of the activities costed.
Central costs can be inputed as LCUs (in the current selected in A1.1) [Column G] or in USD
[Column H]. Column H takes precedence if values are inputed in both currencies. Some names
[Column C] for items can also be updated by the end-user to allow for more customization.
Additional rows are included to cost additional items per category (if desired).
Please start by inputing the desired duration for central-level activities in months below.
1 Duration of central-level initiatives
A4.1-A Planning and Coordination
1 Central-level committees
1 Central-level sub-committees
1 Central-level workshops / stakeholder engagement / training
1 TA: Vaccine procurement approach, incl. costs, due diligence, procurement, monitoring
1 TA: Medical waste management planning, protocols, SOPs (combine A6/H6)
1 Procure waste management equipment [incl. capital investments but excluding supplies]
1 TA: National Deployment and Vaccination Plan (NDVP)
1 Secretariat support (staffing and office expenditures)
2 (additional items can be added here if desired)
2
2
A4.1-B Budgeting
1 TA: Integrated into government budget planning + PFM

2
2
A4.1-C Regulatory
Instructions: Please consider adding regulatory capacity buidling if desired.
1 TA: Expedited regulatory pathways, documentation, importation and lot release processes
2
2
A4.1-D Prioritization, Targeting, and Covid-19 Surveillance
TA: Identify target populations and their geographic location, estimate numbers, and delivery
1 modalities
2
2
1 TA: Link with Covid-19 disease surveillance
A4.1-E Service Delivery

Instructions: This section pertains mainly to technical assistance (TA) related to planning and arrangements for service delivery
not vaccinators or their local supervisors. Do not include the costs of 'delivery' itself (this is costed elsewhere in the tool.
1 TA: Protocols for PPEs and IPC equipment
1 TA: Micro-planning, incl outreach modalities, master lists of providers, logistics, supplies
1 TA: Implementing agencies and contracts: Vaccine logistics and waste management
1 TA: Private provider enrollment, accredditation, SOPs, complaints, monitoring
1 TA: Protocols for consent, refusals, protecting refusals (combine E4/H8)
2
2
A4.1-F Training & Supervision

Instructions: This section includes technical assistance (TA) for developing training plans and materials. Please also include the
and/or digital learning) but exclude local level training (which should be costed under A3.1).
Technical assistance for security planning also is to be included here if desired but security costs at the central stores and at the
1 TA: Development of training plans

1 TA: Translate and adapt WHO and additional training materials
Other TA for HR and training
2
2
1 TA: Security plans for central, regional storage and for vaccinators
1 Conduct the vaccinator Training of Trainers (and Supervision) training [Instructor-led]

[and/or] Conduct the vaccinator Training of Trainers (and Supervision) training [Digital learning -
1 self-paced]
1 Supplementary operational costs / per diems for supervisors at local level
1 Central-level Implementation team
1 Sub-national level 1 implementation team size per admin unit
1 Sub-national level 2 implementation team size per admin unit
1 Training of logistics manpower
Other Vaccinator Training and Supervision
2
2
A4.1-G Monitoring and Evaluation

Instructions: This section may include the development of an electronic vaccination records and related information systems. If
here, equipment costs per site/vaccination team in A3.5, operational costs such as telecommunications in A3.5, and any per-dos
Oversight and assurance costs - can be added under this section (specified as a percent above vaccine and vaccine delivery costs
1 TA: Adapt/develop surveillance and M&E framework (incl. indicators and instruments)
TA: Adapt/develop paper-based or electronic vaccination records system, ensure data protection
1 measures and grievance mechanism
Other Technical Assistance (6.1)
2
2
1 Deploy / distribute / pilot /provide training for vaccination records system

Other Operational Expenditure (6.2)
2
2
1 Vaccination coverage survey

1 Post-introduction evaluation for COVID-19 vaccines
1 Vaccine effectiveness and impact study
Other Evaluations (6.3)
2
2
2 Oversight & Assurance Costs
A4.1-H Vaccine Procurement, Cold chain, Logistics, and Infrastructure

Instructions:: This section includes technical assistance (TA) for various aspects of vaccine-related logistics and infrasturcure.
1 TA: Establish National Logistics Working Group - TORs, SOPs, Key Roles and Responsibilities
1 TA: Distribution strategy for vaccines from point of entry
1 TA: Map, plan, gap assessment - infrastructure needs, incl energy, communications, water
1 TA: Gap assessment: Dry storage and cold chain capacity needs at all levels
1 TA: Medical waste management planning, protocols, SOPs (combine A6/H6)
TA: Supply-chain and logistics integrate existing Vaccine Logistics Management Information
1 System (VLMIS)
1 TA: Protocols for consent, refusals, protecting refusals (combine E4/H8)
2
2
A4.1-I Vaccine Safety Surveillance

Instructions:: This section includes technical assistance (TA), training, and the establishment of a compensation scheme. Funds
section T1) and are tabulated in R2.1.13.
Note: At time of development of this costing platform, specific details of the vaccine candidates and related AEFI, SAR, AESI
estimation of such cost may need further adaptation.
TA: Develop and disseminate guidelines, procedures, tools for vaccine pharmacovigilance and
1 active surveillance of specific Covid-19 vaccine related adverse events
1 TA: AEFI Committee - TORs
TA: Identify provisions that require manufacturers to implement risk management plans and collect
1 and report COVID-19 vaccine safety data to the NRA.
1 TA: Institutional and global linkages and coordination mechanisms, for vaccine pharmacovigilance
TA: Establishment of compensation schemes and policies (excluding the actual funds for no-fault
1 liability)
Other Technical Assistance (7.1)
2
2
1 Training of AEFI investigators

1 Training of AEFI Committee
1 Active surveillance of specific Covid-19 vaccine related adverse events
1 Establish high-quality sentinel site surveillance
2
2
A4.1-J Demand Generation and Communications

Instructions:: Demand generation and communications may be a large driver of vaccination costs. Technical assistance (TA), de
operational costs for these are costed here. Some sub-national costs such as those related to local RCCE focal points and comm
of local demand generation are costed under section A3.6 (for activities originating at vaccination service points - these should
TA: Design social mobilization and engagement strategy, including crisis communications, key
1 messages, communications materials, complaints handling
1 TA: Data collection systems - social media, rumor management, assess behavioural and social data
1 TA: Public messages and materials
2
2
Operational costs: Data collection systems - social media, rumor management, assess behavioural
1 and social data
1 Operational costs: Central RCCE team, crisis communications
1 Mass media and social media communications at central-level
1 Training of RCCE focal points
1 Operational costs for RCCE focal points
1 Community engagement grants
1 Survey / interviews to obtain local behavioural and social data
2
2
A4.1-K Opportunistic co-delivery of essential health services

Instructions:: This section allows activities related to the development of co-delivery of essential health services at the same tim
opportunity to address pre-existing health considerations in the country - for example screening of NCDs, health education, and
populations overlap.
2 Development of co-delivered / additional interventions
2
2
 
Results Help
December 2020) + NDVP activities
Quantity Suggestion Unit Unit Price

Input Here
Input Here
36 Months
2 Committees #N/A
6 Committees #N/A
5 Workshops #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
36 Months #N/A
1 #N/A
1 #N/A
1 #N/A
LCU: Override in USD
1 #N/A
1 #N/A
1 #N/A
1 #N/A

1 #N/A
1 #N/A
1 #N/A
1 #N/A
#N/A
1
1 #N/A
1 #N/A
1 #N/A
1 #N/A

ng and arrangements for service delivery. Staffing and implementation teams should also be included here but
his is costed elsewhere in the tool.
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A

ans and materials. Please also include the costs of training where these originate at the central level (e.g., ToT
A3.1).
urity costs at the central stores and at the local level are covered under B4.2 and B5.
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
0 Per trainer #N/A

#N/A
#N/A Per vaccinator
0 Per supervisor #N/A
Staff #N/A
0 Per team #N/A
0 Per team #N/A
0 Per person #N/A
1 #N/A
1 #N/A
1 #N/A

ords and related information systems. If this is desired, please include technical costs and development costs
ommunications in A3.5, and any per-dose delivered costs in A3.2 (Electronic Records).
above vaccine and vaccine delivery costs, excluding central costs).

1 #N/A
#N/A
1
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
0.00% Percent of vaccine and vaccine delivery costs

cine-related logistics and infrasturcure.
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
#N/A
1
1 #N/A
1 #N/A
1 #N/A
1 #N/A

hment of a compensation scheme. Funds for such a scheme are costed as a fixed amount per dose (under
andidates and related AEFI, SAR, AESI surveillance and investigation activities are not available and hence the
#N/A
1
1 #N/A
#N/A
1
1 #N/A
#N/A
1
1 #N/A
1 #N/A
1 #N/A
0 Per person #N/A

Per person #N/A
0 Per service point / distribution point #N/A
Per site #N/A
1 #N/A
1 #N/A
1 #N/A

ation costs. Technical assistance (TA), development costs for communications activities, and central-level
d to local RCCE focal points and community engagement can also be included here. However, many aspects
vaccination service points - these should be reviewed together to ensure alignment.
#N/A
1
1 #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A
#N/A
36 Months
36 Months #N/A
#N/A Per capita #N/A
0 Per person #N/A
0 Per person #N/A
0 Communities #N/A
1 #N/A
1 #N/A
1 #N/A
1 #N/A

f essential health services at the same time, opportunistically, as the Covid-19 vaccination. This can be the
creening of NCDs, health education, and delivery of other vaccines or health commodities where target
1 #N/A
1 #N/A
1 #N/A
1 #N/A

Next Item
F), 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
#N/A
Category
Sub-Total Total WHO/UNICEF/WB VIRAT-VRAF 2.0
Link to supplementary
data on:
Medical supplies,
equipment and contract
Reference services requirements
#N/A
#N/A A1, A2
#N/A A3
#N/A A4, A7
#N/A A5 More info on vaccine doses, ancilliary supplies, PPE @ B2
#N/A A6/E3/H6
#N/A A6 More info on waste management supples @ B2
#N/A A8
#N/A -
#N/A
#N/A
#N/A
#N/A
#N/A B1, B2
#N/A
#N/A
#N/A
#N/A
#N/A C1-C5
#N/A
#N/A
#N/A
#N/A
#N/A D1, D2
#N/A
#N/A
#N/A
#N/A D3
#N/A
#N/A E1
#N/A E2
#N/A A6/E3/H6
#N/A E3
#N/A E4/H8
#N/A
#N/A
#N/A
#N/A
#N/A F1
#N/A F2
#N/A
#N/A
#N/A
#N/A F3
#N/A F4 / NDVP
#N/A F4 / NDVP
#N/A NDVP
#N/A -
#N/A -
#N/A -
#N/A H3
#N/A
#N/A
#N/A
#N/A
#N/A G1
#N/A G2, G3, G5
#N/A
#N/A
#N/A
#N/A G4
#N/A
#N/A
#N/A
#N/A NDVP
#N/A NDVP
#N/A NDVP
#N/A
#N/A
#N/A
#N/A
#N/A H1, H2
#N/A H3
#N/A H4
#N/A H5 More info on cold chain @ R2.1.05
#N/A A6/E3/H6
#N/A H7
#N/A E4/H8
#N/A
#N/A
#N/A
#N/A
#N/A I1, I5
#N/A I3
#N/A I4
#N/A I5, I6, I7
#N/A I8
#N/A
#N/A
#N/A
#N/A I2
#N/A I3
#N/A I5
#N/A NDVP
#N/A
#N/A
#N/A
#N/A
#N/A J1
#N/A J2
#N/A J3
#N/A
#N/A
#N/A
#N/A J2
#N/A -
#N/A -
#N/A -
#N/A -
#N/A -
#N/A NDVP
#N/A
#N/A
#N/A
#N/A
#N/A -
#N/A
#N/A
#N/A
UNICEF/WB VIRAT-VRAF 2.0 Comments
Link to supplementary data on:

Staffing and training requirements
National Coordination Committee, National Technical Working Group (NTWG)

6 sub-committees described
accine doses, ancilliary supplies, PPE @ B2
waste management supples @ B2 The actual equpment, not TA. Central, regional, and district-level waste management equipment EXCLUDING saf
Unit price per staff per month (incl. office expenses associated with the staff)
Financial, human resources (surge capacity), demand generation, risk communications, safety surveillance, securi
Virtual and/or in-person
More info on vaccinator training @ R2.1.03 Train a supervisor for each region, district, and fixed site. NOTE: Local-level training specified under A3.1.
NOTE: Local-level training also specified under A3.1 - do not double count
More info on vaccinator training @ R2.1.03
Say a provincial team | Unit price per staff per month (incl. office expenses associated with the staff)
Say a district team | Unit price per staff per month (incl. office expenses associated with the staff)
3rd party oversight over delivery to ensure fairness and quality. Percent of delivery costs (Categories 3 [Human R
NOT the actual costs of the upgrades required

old chain @ R2.1.05 NOT the actual costs of the upgrades required. Cold chain capacity needs costed separately in this tool.
Cold-chain logistics, stock keeping
Reporting, investigation, causality assessment, risk communication and response
More info on the no fault compensation fund @ R2.1.07

incl. translation
Price per month
More info @ R2.1.12
NOTE: Local-level demand generation and communications under "Last Mile Delivery"
e.g. engaging with local community leaders and religious leaders

NOTE: Local-level demand generation and communications under "Last Mile Delivery"
User Notes
ste management equipment EXCLUDING safe boxes (which are costed under B2 Vaccines and Supple
k communications, safety surveillance, security planning; gap analysis
cal-level training specified under A3.1.
enses associated with the staff)

ses associated with the staff)
ent of delivery costs (Categories 3 [Human Resources] and 4 [Vaccination Delivery])
eeds costed separately in this tool.

Last Mile Delivery"
Last Mile Delivery"

   
NAVIGATION BAR: Menu Next Item Next Page Results
B1. Estimate Target Population Sizes and Vaccine Requirements

Instructions: Please adjust the timing and prioritization of vaccine introduction in section B1.2 - this is a required part of c
B1.1 Target Population: Total Size | Ground up estimation
2021
Total Population #N/A
Note that the total populaton will be represented in each time period (half year)
Sub-Population Groups
Older Adults #N/A
Children and Younger Adults #N/A
Hard-to-Reach - ALL AGES #N/A
… of which, Older Adults #N/A
… of which, Underlying health conditions among non-older adults #N/A
… of which, Pregnant women #N/A
… of which, Special populations who are Hard-to-Reach #N/A
… of which, remainder (Young Adults and Children) #N/A
Easier-to-Access - ALL AGES #N/A
… of which, Older Adults #N/A
… of which, Underlying health conditions among non-older adults #N/A
… of which, Pregnant women #N/A
… of which, remainder (Young Adults and Children) #N/A
SAGE Target Populations Categories below this should be mutually exc

[A2.2-1] HEALTH WORKERS #N/A
[A2.2-2] ESSENTIAL WORKERS AND RELATED GROUPS #N/A
AGE GROUPS AT HIGH RISK OF TRANSMITTING INFECTION #N/A
[A2.2-3] OLDER ADULTS
OLDER ADULTS in RESIDENTIAL INSTITUTIONS #N/A
AND, SOCIAL CARE WORKERS in RESIDENTIAL INSTITUTIONS #N/A
OLDER ADULTS in the community #N/A
AND, their households members #N/A
Hard-to-Reach OLDER ADULTS #N/A
[A2.2-4] Sociodemographic groups at significantly higher risk of severe disease

or death
… of which , easy-to-access #N/A
.. of which, living in RESIDENTIAL INSTITUTIONS #N/A
AND, STAFF in RESIDENTIAL INSTITUTIONS #N/A
Special populations who are Hard-to-Reach #N/A
"Hard-to-Reach" but no other priority criteria #N/A
[A2.2-5] Groups with comorbidities or health states determined to be at

significantly higher risk of severe disease or death
Hard-to-Reach Underlying health conditions (not pregnant women) #N/A
Easier-to-Access Underlying health conditions (not pregnant women) #N/A
Hard-to-Reach Pregnant Women #N/A
Easy-to-access Pregnant women #N/A
Infer Remainder with no high-priority qualifying conditions #N/A
B1.2 Timing of Target Population Vaccination

INSTRUCTIONS: This critical section is for specifying the prioritization of various SAGE target populations, over the S
Each beige colored row represents one or a collection of several target subpopulations. Prioritization is specified as the pe
to be covered in this 3-year period (2021-2023). This can be zero (if there are no intentions to vaccinate that subpopulatio
greater than 100% if the subpopulation will be vaccinated with more than one course OR if there are expected to be additi
A vaccine surplus and deficit calculator for each time period is provided just below. This can be used to immediately see
The recommended method for completing this section is firstly to start with "0%" for all cells. Next, look for the highest p
'surplus' of vaccine doses for that time period and if not, please adjust the degree of prioritization accordingly to balance t
period (calculator shifts from surplus to 'blank' or deficit), adjust the degree of prioritization to balance the supply and dem
H1 2021
Stage 1
SAGE Target Populations
1 [A2.2-1] HEALTH WORKERS 0%
1 [A2.2-2] ESSENTIAL WORKERS AND RELATED GROUPS 0%
1 OLDER ADULTS in RESIDENTIAL INSTITUTIONS 0%
AND, SOCIAL CARE WORKERS in RESIDENTIAL INSTITUTIONS 0%
1 OLDER ADULTS in the community 0%
AND, their households members 0%
1 Hard-to-Reach OLDER ADULTS 0%
[A2.2-4] Sociodemographic groups at significantly higher risk of severe disease or death

1 … of which , easy-to-access 0%
1 .. of which, living in RESIDENTIAL INSTITUTIONS 0%
AND, STAFF in RESIDENTIAL INSTITUTIONS 0%
1 Special populations who are Hard-to-Reach 0%
1 "Hard-to-Reach" but no other priority criteria 0%
[A2.2-5] Groups with comorbidities or health states determined to be at significantly higher risk of severe disease or death
Hard-to-Reach Underlying health conditions (not pregnant women) 0%
Easier-to-Access Underlying health conditions (not pregnant women) 0%
1 Infer Remainder with no high-priority qualifying conditions 0%
Instructions: This surplus/deficit calculator is to that the implications of vaccination timing can be seen immediately. Ens
influenced by the supply of vaccines (A2.6), expected uptake and wastage (A2.4), and target population specifications (A
Trigger sensi Surplus or deficit? #N/A

0.20%
Vaccine courses needed (considering vaccine wastage and expected
uptake) #N/A
Vaccine courses supplied #N/A
Surplus (+) / Deficit (-) #N/A
B1.2.2 Sites to visit in a time period (FYI only)

H1 2021
Delivery Modality 1 0
Delivery Modality 3 #N/A
… LR Residential Institutions #N/A
… HR Residential Institutions 0
… LR Residential Institutions (interpreted % sequencing) #N/A
… HR Residential Institutions (interpreted % sequencing) 0%
B1.3 Distribution Matrix: How many to vaccinate, how, and when?

H1 2021
Stage 1
SAGE Target Populations
[A2.2-1] HEALTH WORKERS #N/A
[A2.2-2] ESSENTIAL WORKERS AND RELATED GROUPS #N/A
AGE GROUPS AT HIGH RISK OF TRANSMITTING INFECTION #N/A
OLDER ADULTS in RESIDENTIAL INSTITUTIONS #N/A
AND, SOCIAL CARE WORKERS in RESIDENTIAL INSTITUTIONS #N/A
OLDER ADULTS in the community #N/A
Hard-to-Reach OLDER ADULTS #N/A
[A2.2-4] Sociodemographic groups at significantly higher risk of severe disease

or death
… of which , easy-to-access #N/A
.. of which, living in RESIDENTIAL INSTITUTIONS #N/A
AND, STAFF in RESIDENTIAL INSTITUTIONS #N/A
Special populations who are Hard-to-Reach #N/A
"Hard-to-Reach" but no other priority criteria #N/A
[A2.2-5] Groups with comorbidities or health states determined to be at

significantly higher risk of severe disease or death
Hard-to-Reach Underlying health conditions (not pregnant women) #N/A
Easier-to-Access Underlying health conditions (not pregnant women) #N/A
Hard-to-Reach Pregnant Women #N/A
Easy-to-access Pregnant women #N/A
Infer Remainder with no high-priority qualifying conditions #N/A
Total Total to be targeted during the period #N/A
B1.3.1 Full Take-Up (Vaccine courses) #N/A

Note: Assumes that all those offered the COVID-19 vaccine will take-up the offer | No vaccine wastage
Work-based | Delivery Modality 1 or 2 #N/A
Work-based | Delivery Modality 1 #N/A
Voluntary | Delivery Modality 1 or 2 #N/A
Voluntary | Delivery Modality 1 #N/A

Total #N/A
Note: Assumes that all those offered the COVID-19 vaccine will take-up the offer | No vaccine wastage | Round UP
ChAdOx1-S (COVISHIELD) #N/A
Total #N/A
B1.3.2 Expected Uptake (Vaccine courses) #N/A

Note: Applies the expected take-up assumption | No vaccine wastage | Round UP
Total #N/A
Note: Applies the expected take-up assumption | No vaccine wastage | Round UP

Total #N/A
B1.4 Vaccine Courses Needed, considering Vaccine Wastage Rate

Note: Assumes that all those offered the COVID-19 vaccine will take-up the offer | But vaccine wastage rate applied
Total #N/A
Note: Applies the expected take-up assumption | But vaccine wastage rate applied
2 ChAdOx1-S (COVISHIELD) #N/A
Total #N/A
1-dose vaccines (number of courses) -

2-dose vaccines (number of courses) #N/A
Total #N/A
B1.4.1 Summary - Vaccines courses needed in 2021 (Stage 1 and 2)
Needs (
Needs estimation parameters --> Full Uptake + Wastage

Total Courses Needed | Supplied #N/A
Percent of 2020 Population #N/A
B1.4.2 Summary - Vaccines courses needed in 2021 Stage 1 (The first 3% ~ H1 2021)
Needs (

Total #N/A
B1.4.3 Summary - Vaccine courses needed in 2021 Stage 2
Needs (

Total #N/A
 
Results Help
B1.2 - this is a required part of completing this costing platform.

YEAR
2021 2022 2023
#N/A #N/A #N/A #N/A
Sub-Population Calculations (not MECE)

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
low this should be mutually exclusive, commonly exhaustive

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
HALF-YEARLY TIME PERIOD

E target populations, over the Stage I, II, and III (approximately 2021-2023).
oritization is specified as the percent of that subpopulation (row) which is to be vaccinated in the half-yearly time period (column). The total of each
s to vaccinate that subpopulation), less than 100% if not all of the subpopulation is to be vaccinated, exactly 100% if the subpopulation will be vaccin
f there are expected to be additional 'new' people in the subpopulation (e.g. newly recruited health workers, newly diagnosed diabetics, etc.) within th
can be used to immediately see the implications of the prioritization against the supply of vaccine doses for the that time period.
ells. Next, look for the highest priority target subpopulation and maximize (fill in the highest percentage permissable) in the earliest time period. Chec
ization accordingly to balance the supply and demand for vaccines. Next, move to the next priority target subpopulation and repeat the process. When
on to balance the supply and demand for vaccines and move on to repeating the same process for the next time period.
H2 2021 H1 2022 H2 2022 H1 2023

Stage 2
PLEASE EDIT THE SHADED CELLS BELOW
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
isk of severe disease or death

0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
0% 0% 0% 0%
g can be seen immediately. Ensure that supply and demand are closely balanced … fewer than 1000 courses discrepency. The calculations are also
get population specifications (A2.2)
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
H2 2021 H1 2022 H2 2022 H1 2023

0 0 0 0
0 0 0 0
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
0 0 0 0
#N/A #N/A #N/A #N/A
0% 0% 0% 0%
0 0 0 0
HALF-YEARLY TIME PERIOD

H2 2021 H1 2022 H2 2022 H1 2023
Stage 2
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
ge | Round UP
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
ge rate applied
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
- - - -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
Needs (Demand-sde estimates) Estimated value of fully loaded vaccine
Expected Uptake + No
Full Uptake + No Wastage Expected Uptake + Wastage Wastage No fault compensation fund
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
Needs (Demand-sde estimates)
Full Uptake + No Wastage Expected Uptake + Wastage Wastage
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
Needs (Demand-sde estimates)
Full Uptake + No Wastage Expected Uptake + Wastage Wastage
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
1. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
Comments
2023 Delivery Modality
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A Work DM1

#N/A Work DM1 / DM2
#N/A Voluntary DM1 / DM2
#N/A DM3
#N/A DM3
#N/A DM4
#N/A DM4

#N/A DM3
#N/A DM3
#N/A DM4
#N/A DM4
#N/A DM4
#N/A DM4
#N/A DM4
#N/A #N/A Voluntary DM1 / DM2 Ensure no negative number
Comments
me period (column). The total of each row represents the percent of the subpopulation
% if the subpopulation will be vaccinated with one course over the 3-year period; or
ly diagnosed diabetics, etc.) within the 3-year priod.
hat time period.
sable) in the earliest time period. Check that the calculator still indicates that there is a
pulation and repeat the process. When the vaccine doses are exhausted for that time
eriod.
re t
He pu
In
H2 2023 100% ≈
3-year total 100%

0% 0% #N/A Work DM1
0% 0% #N/A Work DM1 / DM2
0% 0% #N/A DM3
0% #N/A DM3
0% 0% #N/A Voluntary DM1 / DM2
0% #N/A Voluntary DM1 / DM2
0% 0% #N/A DM4
0% DM4

0% 0% #N/A DM3
0% #N/A DM3
0% 0% #N/A DM4
0% 0% #N/A DM4
0% 0% #N/A DM4
0% #N/A DM4
0% #N/A Voluntary DM1 / DM2
crepency. The calculations are also 

Next Item
#N/A CHECK Adjust timing of coverage in H1 and H2 2021 to avoid surpluses or deficits
#N/A #N/A
#N/A #N/A
#N/A Vaccine courses (not doses)
H2 2023 Total
0 - Every site every time peiod
0 - Every site every time peiod
#N/A #N/A Each site once during entire program - distribute according to population cove
#N/A #N/A Ensure no negative numbers here - please adjust the timing in B1.2 for residen
0 OK Ensure no negative numbers here - please adjust the timing in B1.2 for residen
#N/A
0%
0 - Repeated visits = 0 Distribute visits according to population coverage - noting that if cover HR an
Repeated visits
H2 2023 Total Delivery Modality
#N/A #N/A Work DM1

#N/A #N/A Work DM1 / DM2
#N/A #N/A Voluntary DM1 / DM2
#N/A #N/A DM3

#N/A #N/A DM3
#N/A #N/A DM4
#N/A #N/A DM4

#N/A #N/A DM3
#N/A #N/A DM3
#N/A #N/A DM4
#N/A #N/A DM4
#N/A #N/A DM4

#N/A #N/A DM4
#N/A #N/A DM4
#N/A #N/A
#N/A #N/A
Delivery Modality These estimates useful for demand-generation interventions
#N/A #N/A Wrk DM1 / DM2 Allow for differences in communications costs and expected uptake
#N/A #N/A
#N/A #N/A
#N/A #N/A Vol DM1 / DM2 Allow for differences in communications costs and expected uptake
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A Delivery Modality 1

#N/A #N/A
#N/A #N/A
Expected Uptake These estimates useful for last-mile service provision
#N/A #N/A 0%
#N/A #N/A 0%
#N/A #N/A 0%
#N/A #N/A 0%
#N/A #N/A 0%
#N/A #N/A 0%
#N/A #N/A

#N/A #N/A
WMF
#N/A #N/A 1.000 Delivery Modality 1
#N/A #N/A
These estimates useful for expected vaccine doses used

#N/A #N/A
- -
#N/A #N/A
#N/A #N/A
ated value of fully loaded vaccine components
Vaccine-related
Waste Management devices and supplies
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A Covax 20% *SUPPLY* allocation assumed to be based on 2020 population (U
failed - Errors = 1
User Notes
no negative number
User Notes
ming of coverage in H1 and H2 2021 to avoid surpluses or deficits

courses (not doses)
te every time peiod

te every time peiod
e once during entire program - distribute according to population coverage
no negative numbers here - please adjust the timing in B1.2 for residential institutions for high risk age groups - do not spread out
no negative numbers here - please adjust the timing in B1.2 for residential institutions for low risk age groups - do not spread out t
te visits according to population coverage - noting that if cover HR and LR at the same time, don't need to visit again (except for do
timates useful for demand-generation interventions

r differences in communications costs and expected uptake
r differences in communications costs and expected uptake
timates useful for last-mile service provision
timates useful for expected vaccine doses used

0% *SUPPLY* allocation assumed to be based on 2020 population (UN WPP 2019 Revision; No vaccine wastage)
  
B2. Vaccines and Supplies | Ground-up estimations based on defined target population
Note: No user editable cells in this sheet - FYI only
B2.0
Item Notes
B2.1.1 Delivery Modality 1 ChAdOx1-S (COVISHIELD) 2 # Courses:
Doses per course
Vaccine doses Add wastage rate + doses per course
1 Without wastage
-1 Expected # of investigable AEFIs 0
Note: Waste Multiplication Factor TO BE incorporated

0 Low Dead Space Syringe (0.3ml) AD 0
1 Syringe (0.5ml) AD 1.05
2 23G needle 1.05
3 Alcohol Swab, Plaster, Dry Swabs 1.05
4 21G needle 0
5 Sodium Chloride 0.9 % ampule 10mls 0
6 RUP syringe (3ml) 0
7 … 0
8 … 0
9 Sharps Disposal (5L) 0.01
10 Vaccination Card 1.05
11 Electronic Records 1
12 No fault compensation fund 0.05

1 Without wastage

2 23G needle 1.05
4 21G needle 0
7 … 0
8 … 0

1 Without wastage

2 23G needle 1.05
4 21G needle 0
7 … 0
8 … 0

1 Without wastage

2 23G needle 1.05
4 21G needle 0
7 … 0
8 … 0
B2.2 TOTALS
Vaccine doses (all vaccines)
Expected # of investigable AEFIs
0 Low Dead Space Syringe (0.3ml) AD

1 Syringe (0.5ml) AD
2 23G needle
3 Alcohol Swab, Plaster, Dry Swabs
4 21G needle
5 Sodium Chloride 0.9 % ampule 10mls
6 RUP syringe (3ml)
7 …
8 …
9 Sharps Disposal (5L)
10 Vaccination Card
11 Electronic Records
12 No fault compensation fund
Large, long range, cold box (20L)

Vaccine carrier (1.5L)
Icepacks
PPEs
Vaccinator-Days
Quantity (per Vaccinator-Days) Unit Cost (USD)
13 Medical mask 2.00 #VALUE!
14 Alcohol-based hand rub (1L) ### #VALUE!
15 Liquid soap and water ### #VALUE!
16 … 0.00 $ -
17 … 0.00 $ -
18 … 0.00 $ -
19 … 0.00 $ -
20 … 0.00 $ -
0.00 #N/A
0.00 #N/A
0.00 #N/A
0.00 #N/A
0.00 #N/A
New additional vaccinators

Quantity (per Vaccinator-Days) Unit Cost (USD)
21 Eye protection 0.00 $ 5.00
22 Face shield 0.00 $ 5.00
23 … 0.00 $ -
24 … 0.00 $ -
25 … 0.00 $ -
0.00 #N/A
0.00 #N/A
0.00 #N/A
0.00 #N/A
0.00 #N/A
 
Results Help
arget population
Quantities (Units)
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
#N/A #N/A #N/A #N/A #N/A #N/A

on Factor TO BE incorporated in Vaccine Candidate Database








H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023

#N/A
-
#N/A
Cold boxes, vaccine car
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023

Quantity
#VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!
#VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!

Quantity
ome rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
Costs (USD)
Total H1 2021 H2 2021 H1 2022 H2 2022
Value of loaded supplies (excl. procurement agent fees)
#N/A #VALUE! #N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A #N/A

#N/A
#N/A

#N/A $ - #N/A #N/A #N/A #N/A
#N/A $ 0.05 #N/A #N/A #N/A #N/A

#N/A
#N/A

#N/A $ - #N/A #N/A #N/A #N/A
#N/A $ 0.05 #N/A #N/A #N/A #N/A

#N/A
#N/A

#N/A $ - #N/A #N/A #N/A #N/A
#N/A $ 0.05 #N/A #N/A #N/A #N/A

Max
#N/A
#N/A #N/A

#N/A $ - #N/A #N/A #N/A #N/A
#N/A $ 0.050 #N/A #N/A #N/A #N/A
#N/A
Total H1 2021 H2 2021 H1 2022 H2 2022
#N/A
#N/A
#N/A

#VALUE!
$ -
#N/A
Cold boxes, vaccine carriers, and ice packs #VALUE!
Total Vaccine Related Supplies #N/A #N/A #N/A #N/A
Total H1 2021 H2 2021 H1 2022 H2 2022

#N/A
Cost
#N/A #VALUE! #VALUE! #VALUE! #VALUE!
#VALUE! #VALUE! #VALUE! #VALUE! #VALUE!
#VALUE! #VALUE! #VALUE! #VALUE! #VALUE!
#N/A
Cost
Total PPE #N/A #N/A #N/A #N/A

sts (USD)
H1 2023 H2 2023 Total
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2023 H2 2023 Total
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2023 H2 2023 Total
#VALUE! #VALUE! #VALUE!

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

No wastage #'s - as wastage added to vaccine-related to supplies already
Subject to custom clearance?
Please see Sheet A3.2 to change these

No
No
No
No
No
No
No
No
No
Note: Mapped to R2.1 - 4.2 Waste Management
Note: Mapped to R2.1 - 6.2 Data Management
Note: Mapped to R2.1 - 6.2 Data Management
Note: Mapped to R2.1 - 7.3 No Fault Compensation
Please see Sheet A3.5 to change these
Note: Mapped to R2.1 - 5. Supply Chain including Cold Chain
(excludes Electronic Records and Compensation)

   
NAVIGATION BAR: Menu Menu Next Page Results
Note: No user editable cells in this sheet - FYI only
B3.1 International Shipping (Based on demand estimates) #N/A

Combine shipments? Yes
International shipments per period 2
Destination #N/A
H1 2021
Manufacturing source country Doses Needed (Based on dem
ChAdOx1-S (COVISHIELD) AstraZeneca #N/A
Weight per dose (g) in secondary packagingWeight of vaccines in second

ChAdOx1-S (COVISHIELD) 2 #N/A
#N/A
Volume
Volume per dose (cm3) in secondary packaging of vaccines in secon
ChAdOx1-S (COVISHIELD) 2.1 #N/A
Shipments Combined
Vaccine Cold Storage Requirements Number of pallet sized conta

-7 ChAdOx1-S (COVISHIELD) Refrigerated (2 to 8C) #N/A
#N/A
Number of parcel sized conta
Room temperature #N/A
Refrigerated (2 to 8C) #N/A
Frozen (-20C) #N/A
Ultra-cold (-60 to -80C) #N/A
#N/A
Number of pallet sized conta
Frozen (-20C) #N/A
#N/A
Frozen (-20C) #N/A
#N/A
Room temperature
Refrigerated (2 to 8C)
Frozen (-20C)
Ultra-cold (-60 to -80C)
Weight of cold chain packaging (kg) per Shipment #N/A
Room temperature
Frozen (-20C)
Price of cold chain packaging per Shipment #N/A
Billing weight and Shipment

Pallet Volumetric Weight 595.2
Parcel Volumetric Weight 27.6
Volumetric Weight #N/A
Actual Weight #N/A
Billing Weight #N/A
Shipping Costs per Shipment #N/A
Shipping Costs per Period #N/A
Shipments #N/A
Shipments Separate
Vaccine Cold Storage Requirements Number of pallet sized conta


Frozen (-20C) #N/A
Weight of cold chain packagi

Price of cold chain packaging

Billing weight and Shipment
Actual Weight #N/A
Actual Weight #N/A
Actual Weight #N/A
Actual Weight #N/A
Billing Weight #N/A
Billing Weight #N/A
Billing Weight #N/A
Billing Weight #N/A
Shipping Costs per Shipment (all vaccine types) #N/A
Shipping Costs per Period #N/A
Shipments 0
B3.2 Electronic Temperature Monitoring Device #N/A
Electronic temperature monitoring device per container per period #N/A
B3.4 Ground Handling $ -

Ground handling costs $ -
Total handling and other $ -
Shipping per dose (to estimate / unbundle Covax fully-loaded vaccine doses) #N/A
 
Results Help
2 2 2 2 2
H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

s Needed (Based on demand estimates)
ght of vaccines in secondary packaging (kg) per Shipment

me of vaccines in secondary packaging (liters) per Shipment, incl. buffer 1.25
ber of pallet sized containers Max Payload 1121

ber of parcel sized containers Max Payload 25.8
ber of pallet sized containers
ber of parcel sized containers
ng weight and Shipment Costs

ber of pallet sized containers

ber of parcel sized containers

ght of cold chain packaging (kg) per Shipment

of cold chain packaging per Shipment

ng weight and Shipment Costs
0 0 0 0 0
$ - $ - $ - $ - $ - $ -
$ - $ - $ - $ - $ - $ -
$ - $ - $ - $ - $ - $ -
ome rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
###
Not
Source: https://www.who.int/immunization_standards/vaccine_quality/Vaccines_Shipping_Guidelines082019.pdf
B3.
Combine different vaccines types with similar cold-storage requirements into one shipment?
Assumes shipments divided equally over a period (size and timing)
Assumes shipments are between one manufacturing country (per vaccine) and one central store/warehouse in the destination country
H1
Man
)‫بناء على تقديرات الطلب‬
ً ( ‫الجرعات المطلوبة‬
We
Vol
Ship
Volume threshold above which it is cheaper to use pallet
Once more than n parcels needed - cheaper to go for a pallet (as per simulation on T Shipping ~ variable assumptions are vaccine density and shipping rates )
Roo
Ref
Fro
Ultr
Num
Roo
Ref
Fro
No costing information for this as ultracold services limited in availability
Num
Roo
Ref
Fro
Pall

We

Pric
Bill
Pall
Parc
Vol
Act
Bill
Ship
Ship
Ship
Ship
Vac
‫اللقاح‬
Num
Roo
Ref
Fro
We
Pric
Bill
Vol
Vol
Vol
Vol
Act
Act
Act
Act
Bill
Bill
Bill
Bill
Ship
Ship
Ship
Ship
Ship
Ship
Ship
B3.
https://www.who.int/immunization_standards/vaccine_quality/Vaccines_Shipping_Guidelines082019.pdf
B3.
Tot
Ship

NAVIGATION BAR: Menu
B4. Domestic Logistics - Cold Chain and Security

ADVANCED USERS: Cold chain parameters can be adjusted here.
B4.1 Cold Chain
Logistics Assumptions and Pre-calculations
Number of health facilities with cold-storage - Fixed sites with cold-
storage
Vaccination deliveries from central to fixed sites, per time period
Rural Population %
Population in the largest city %
Surface Area (sqkm)
For population outside the largest city

Half of the radius, assume country is a circle
For population inside the largest city
2 Assume distance is 10km
Weighted (inside and outside largest city) average distance (km)
Surface Area (sqkm) covered by each region on average

Half of the radius, assumption for regional to district travel (km))
Surface Area (sqkm) covered by each fixed site

Half of the radius, assume fixed site catchment area is round (km)
DM2 site distances
DM4 site distances
2 Distance from fixed sites to DM3 Institutions (km)

Cold chain assumptions and precalculations
Volume of COVID-19 vaccines in secondary packaging (liters) per Period, incl. buffer
-7 ChAdOx1-S (COVISHIELD)
Any
For each delivery modality, just prior to use in on-site or by outreach, where are vaccines stored?
ChAdOx1-S (COVISHIELD)
Volume of COVID-19 vaccines in secondary packaging (liters) per Period, incl. buffer, in ALL DISTRICTS, by delivery mod
Volume of COVID-19 vaccines in secondary packaging (liters) per Period, incl. buffer, in ALL FIXED SITES, by delivery m
Population vaccinated by regions directly, by delivery modality

Population vaccinated by district directly, by delivery modality

Population vaccinated by fixed sites, by delivery modality

Population vaccinated at fixed sites, using which vaccine cold chain requirements?
Frozen (-20C)
Maintenance costs from PATH TCO tool http://www.coldchaintco.org/calculate?t=TCO_DETAILED
B4.1.1 Central Store Cold Chain (either WICR and/or WIFR)
2
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer
Frozen (-20C)
Volume of existing routine vaccines required (liters)
2 Refrigerated (2 to 8C)
2 Frozen (-20C)
2 Ultra-cold (-60 to -80C)
Cold storage units required (WICR and WIFR) for COVID-19 + routine vaccines
2
2 Frozen (-20C)
2 Remote Temperature Monitoring Devices
MINUS existing cold-storage units (WICR and WIFR)
2 Frozen (-20C)
2 Use Lower [1] or Upper [2] price?

Capital and Operational Expenditures
Frozen (-20C)
Remote Temperature Monitoring Devices
Frozen (-20C)
Electricity
B4.1.2 Regional Cold Chain

Assumptions: 100% on-grid; ice pack freezer needs user-defined
2 #of ice pack freezers per region
2 Shipments from central to regional per period (User customizati

Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER REGION}
Frozen (-20C)
Volume of existing routine vaccines required (liters) [PER REGION]
2 Frozen (-20C)
Cold storage units required [PER REGION]
2 Frozen (-20C)
Ice pack freezers
MINUS existing cold-storage units
2 Frozen (-20C)
2 Ice pack freezers
Upper or lower price

Capital and Operational Expenditures [ALL REGIONS]
Frozen (-20C)
Ice pack freezers
Total (All Regions) Cold Storage - Capital Expenditu
Frozen (-20C)
Ice pack freezers
Electricity
Total (All Regions) Cold Storage - Operational Expenditu
B4.1.3 District Cold Chain

Assumptions: User-defined proportion of districts on-grid vs solar. On-grid districts with user defined number of ice pack freezers
2 #of ice pack freezers per district
Districts requiring SDD - off-grid
Districts - on-grid
Maximum days that UCC vaccine is stable at 2-8C
2 Shipments from regional to district + health facilities per period (User customizati
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER DISTRICT]
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER DISTRICT]
Frozen (-20C)
Refrigerated (2 to 8C) (TOTAL incl UCC)
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER DISTRICT] - For UCC scena
Volume of existing routine vaccines required (liters) [PER DISTRICT]
2 Frozen (-20C)
Cold storage units required

Solar
2 Frozen (-20C)
On-grid
2 Frozen (-20C)
Ice pack freezers

Solar
2 Frozen (-20C)
On-grid
2 Frozen (-20C)
2 Ice pack freezers
2
Frozen (-20C)
Ice pack freezers
Total (All Districts) Cold Storage - Capital Expenditu
Solar Refrigerated (2 to 8C)

Frozen (-20C)
On-grid Refrigerated (2 to 8C)
Frozen (-20C)
Ice pack freezers
Electricity
Total (All Districts) Cold Storage - Operational Expenditu
B4.1.4 Fixed Sites with Cold Chain

Assumptions: User-defined proportion of districts on-grid vs solar. On-grid districts with user defined number of ice pack freezers
2 #of ice pack freezers per fixed site
Fixed sites requiring SDD - off-grid
Fixed Sites - on-grid
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER FIXED SITE]
Volume of COVID-19 vaccines in secondary packaging (liters) per Shipment, incl. buffer [PER FIXED SITE]
Frozen (-20C)
Refrigerated (2 to 8C) (TOTAL incl UCC)
Volume of existing routine vaccines required (liters) [PER FIXED SITE]
Frozen (-20C)
Cold storage units required

Solar
2 Frozen (-20C)
On-grid
2 Frozen (-20C)
Ice pack freezers

Solar
2 Frozen (-20C)
On-grid
2 Frozen (-20C)
2 Ice pack freezers
2
Frozen (-20C)
Ice pack freezers
Total (All Fixed Sites) Cold Storage - Capital Expenditu
Solar Refrigerated (2 to 8C)

Frozen (-20C)
On-grid Refrigerated (2 to 8C)
Frozen (-20C)
Ice pack freezers
Electricity
Total (All Fixed Sites) Cold Storage - Operational Expenditu
B4.1.5 Summary of new CCE required

Central
2 WICR
2 WIFR
2 UCC
Regions
ILR
ILFR or Freezer
UCC
Districts - Solar
SDD Refridgerator
SDD Freezer or Refridgerator-Freezer
Districts - On-grid
ILR
ILFR or Freezer
Fixed sites - Solar
SDD Refridgerator
SDD Freezer or Refridgerator-Freezer
Fixed Sites - On-grid
ILR
ILFR or Freezer
Others
Remote Temperature Monitoring Devices @ Districts and Fixed Sites
Ice pack freezers @ Regions and Districts
Based on Gavi CCE Budget

Update: 2021-01-20
B4.1.6 Cold chain transportation

Cold chain transportation from central to regional
Room temperature
Frozen (-20C)
Min volume (L) per container (quantize up)

20 Frozen (-20C)
Cold chain transportation from regional store to districts
Room temperature
Frozen (-20C)
UCC Vaccine in 2 to 8C
Min volume (L) per container (quantize up)

5 Frozen (-20C)
5 UCC Vaccine in 2 to 8C
Cold chain transportation from district to fixed sites
Room temperature
Frozen (-20C)
5 Frozen (-20C)
Cold chain transportation from regional store to fixed sites (UCC ONLY)
UCC Vaccine in 2 to 8C
5 UCC Vaccine in 2 to 8C
23
B4.2 Security (for FCAS)
Security during vaccine transport from central to regio
   
Menu Next Page Results Help
#N/A #N/A
#N/A #N/A
0
2
#N/A
#N/A
#N/A
#N/A
10 10 Advanced Users: This largest city distance assumption can be
#N/A
District-equivalent
#N/A #N/A
#N/A #N/A
#N/A
#N/A
#N/A
#N/A
5.0 5 Advanced Users: This distance assumption can be modified
per Period, incl. buffer

Refrigerated (2 to 8C) #N/A #N/A
#N/A #N/A
utreach, where are vaccines stored? Regions Districts

Fixed Sites 0% 0%
Campaigns 30% 40%
Residential Institutions 30% 40%
Outreach 30% 40%
Methodological note: All vaccines flow through the regions. All vaccines going to fixed
per Period, incl. buffer, in ALL DISTRICTS, by delivery modality
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
per Period, incl. buffer, in ALL FIXED SITES, by delivery modality

#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A


Cold storage requirements

chain requirements?
#N/A #N/A
#N/A #N/A
#N/A #N/A
ntco.org/calculate?t=TCO_DETAILED Spare Parts Per 10-y Maintenance & Repair

Walk-in Cold Room or Freezer Room (WICR/FR) $ - $ 840.00
Ice-lined Refridgerator (ILR) $ 51.00 $ 983.00
Freezer $ 42.00 $ 997.00
Solar Direct Drive (SDD) Refridgerator or Freezer $ 58.00 $ 693.00
UCC $ 126.00 $ 2,991.00
#N/A #N/A
H1 2021 H2 2021
International shipments per period (User customization)
per Shipment, incl. buffer 2 2
per Shipment, incl. buffer

#N/A #N/A
#N/A #N/A
#N/A #N/A
9 + routine vaccines Refridgerator capacity p Freezer capacity per uni
WHO PQS CCEs - NO ENDORSEMENT OF ANY PRODUCT - USER TO CHOOSE PRODUCT AS DESIRED
40 cbm - Zhendre 40 cbm (Mono cooling unit) 40,000.0 -
40 cbm - Porkka 40cbm (Mono cooling unit) 25,000.0 15,000.0
UCC - Ultra-cold freezer (Extra Large) 900.0
Haier U-Cool (Refrigerator model)+ 3 years data/portal access
40 cbm - Zhendre 40 cbm (Mono cooling unit)

40 cbm - Porkka 40cbm (Mono cooling unit)
1 Lower (Easier to access facilities)
Central Cold Storage - Capital Expenditures #N/A
$ 42.00 #N/A #N/A

$ 42.00 #N/A #N/A
$ 155.85 #N/A #N/A
#N/A #N/A
Central Cold Storage - Operational Expenditures #N/A #N/A
#N/A #N/A
2 2
H1 2021 H2 2021
Shipments from central to regional per period (User customization)
per Shipment, incl. buffer [PER REGION} 2 2
#N/A #N/A
#N/A #N/A
#N/A #N/A
Refridgerator capacity p Freezer capacity per uni

120L+ - HBC 260 211.0 -
120L+ - HBD 286 - 298.0
UCC - Ultra-cold freezer (Extra Large) 900.0
No model choice
Total Required in All Regions

120L+ - HBC 260 #N/A
120L+ - HBD 286 #N/A
UCC - Ultra-cold freezer (Extra Large) #N/A
No model choice 0
Haier U-Cool (Refrigerator model)+ 3 years data/portal a #N/A
1 Lower (Easier to access facilities)
Total (All Regions) Cold Storage - Capital Expenditures #N/A
$ 51.70 #N/A #N/A

$ 51.95 #N/A #N/A
$ 155.85 #N/A #N/A
$ 51.95 $ - $ -
#N/A #N/A
Total (All Regions) Cold Storage - Operational Expenditures #N/A #N/A
#N/A #N/A
. On-grid districts with user defined number of ice pack freezers
1 1
0
0
5 5
UCC Only #N/A #N/A
UCC Only #N/A #N/A
UCC Only #N/A #N/A
H1 2021 H2 2021
m regional to district + health facilities per period (User customization)
per Shipment, incl. buffer [PER DISTRICT] 2 2
per Shipment, incl. buffer [PER DISTRICT]

#N/A #N/A
#N/A #N/A
and UCC vaccines (will be stored in 2-8C in districts) #N/A #N/A
#N/A #N/A
per Shipment, incl. buffer [PER DISTRICT] - For UCC scenario (regional to district terminus)
and UCC vaccines (will be stored in 2-8C in districts) #N/A #N/A
120L+ - HTC-240 (Ground Mount) 200.0 -
60-90L - TFW 40 SDD (Ground Mount) - 64.0
120L+ - HBC 260 211.0 -

90-120L - DW-25W147 - 96.0
No model choice
Total Required in All Districts

120L+ - HTC-240 (Ground Mount) #N/A
60-90L - TFW 40 SDD (Ground Mount) #N/A
120L+ - HBC 260 #N/A

90-120L - DW-25W147 #N/A
0
Upper (Harder to
2 access facilities) Solar
Lower Price
#N/A
#N/A
#N/A
Total (All Districts) Cold Storage - Capital Expenditures #N/A
$ 37.55 #N/A #N/A

$ 37.55 #N/A #N/A
$ 51.70 #N/A #N/A
$ 51.95 #N/A #N/A
$ 51.95 $ - $ -
#N/A #N/A
Total (All Districts) Cold Storage - Operational Expenditures #N/A #N/A
#N/A #N/A
. On-grid districts with user defined number of ice pack freezers
1 1
0
0
H1 2021 H2 2021
per Shipment, incl. buffer [PER FIXED SITE]
per Shipment, incl. buffer [PER FIXED SITE]

#N/A #N/A
#N/A #N/A
#N/A #N/A

30-60L - HTC 110 SDD (Ground Mount) 59.0 -
30-60L - VFS 048 SDD (Ground Mount) - 34.3
30-60L - GVR 51 Lite AC 51.0 -

30-60L - GVR 55 FF AC 58.0 44.0
No model choice
Total Required in All Fixed Sites

30-60L - HTC 110 SDD (Ground Mount) #N/A
30-60L - VFS 048 SDD (Ground Mount) #N/A
30-60L - GVR 51 Lite AC #N/A

30-60L - GVR 55 FF AC #N/A
0
Upper (Harder to
2 access facilities) Solar
Lower Price
#N/A
#N/A
#N/A
Total (All Fixed Sites) Cold Storage - Capital Expenditures #N/A
$ 37.55 #N/A #N/A

$ 37.55 #N/A #N/A
$ 51.70 #N/A #N/A
$ 51.95 #N/A #N/A
$ 51.95 $ - $ -
#N/A #N/A
Total (All Fixed Sites) Cold Storage - Operational Expenditures #N/A #N/A
New Units Required

40 cbm - Zhendre 40 cbm (Mono cooling unit) #N/A
40 cbm - Porkka 40cbm (Mono cooling unit) #N/A Total ILRs/SDDs/Ice pack freezers
Haier U-Cool (Refrigerator model)+ 3 years data/portal #N/A
120L+ - HBC 260 #N/A

120L+ - HBD 286 #N/A
120L+ - HTC-240 (Ground Mount) #N/A

60-90L - TFW 40 SDD (Ground Mount) #N/A
120L+ - HBC 260 #N/A

90-120L - DW-25W147 #N/A
30-60L - HTC 110 SDD (Ground Mount) #N/A

30-60L - VFS 048 SDD (Ground Mount) #N/A
30-60L - GVR 51 Lite AC #N/A

30-60L - GVR 55 FF AC #N/A

0
Total Capital Expenditures for Cold Chain #N/A

Value (for customs clearance) #N/A
Total cooling units #N/A
International shipment #N/A

Note: Currently not calculated in this tool: Ground handling, ground transport
#N/A #N/A
H1 2021 H2 2021
Per Trip
$ - #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
Per Volume (liters)
#N/A #N/A #N/A
#N/A #N/A #N/A
$ 8.60 #N/A #N/A
#N/A #N/A
Per Trip
$ - #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
$ - #N/A #N/A
#N/A #N/A
Per Volume (liters)
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
Per Trip
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
Per Volume (liters)

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A
Per Trip
#N/A #N/A #N/A
#N/A #N/A
Per Volume (liters)

#N/A #N/A #N/A
#N/A #N/A
Dry ice required per period (kg) #N/A #N/A
#N/A #N/A
Security at central store #N/A #N/A
Security during vaccine transport from central to regional #N/A #N/A
dren’s Fund (UNICEF), 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
oyment_tool/2021.2
Logic checks passed
Users: This largest city distance assumption can be modified
Users: This distance assumption can be modified
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
Fixed Sites
100%
30%
30%
30%
flow through the regions. All vaccines going to fixed sites flow through districts.
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A




#N/A
Per Time Period
$ 42.00
$ 51.70
$ 51.95
$ 37.55
$ 155.85 3

H1 2022 H2 2022 H1 2023 H2 2023 Peak in Central Store
Leave Blank
2 2 2 2
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
Methodological note: The largest shipment size (plu

Liters
Fill here if known
-
-
-
kWh per period per unit Lower Price Upper Price Prequalified Price Units
PRODUCT AS DESIRED
9,180 $ 43,508 $ 51,008 $ 25,008 #N/A
9,180 $ 61,200 $ 73,200 $ 35,200 #N/A
1,872 $ 8,212 $ 8,212 $ 6,912 #N/A
$ 650 $ 850 $ 450 #N/A
Total Pre-existing in Central Store (FILL HERE) Remainder Required in Central Store
0 #N/A
0 #N/A
0 #N/A
0 #N/A
Lower Price Upper Price
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
H1 2022 H2 2022 H1 2023 H2 2023 Peak in Average Region

Leave Blank
2 2 2 2
Liters
Fill here if known
-
-
-
kWh per period Lower Price Upper Price Prequalified Price Units
PRODUCT AS DESIRED
292 $ 1,468 $ 2,418 $ 1,068 #N/A
785 $ 1,028 $ 1,978 $ 628 #N/A
1,872 $ 8,212 $ 8,212 $ 6,912 #N/A
360 $ 1,600 $ 1,600 $ 1,600 2
$ 650 $ 850 $ 450 #N/A
Total Pre-existing in All Regions (FILL HERE) Remainder Required in All Regions
0 #N/A
0 #N/A
MINUS 0 EQUALS #N/A
0 0
0 #N/A
Lower Price Upper Price
#N/A #N/A
#N/A #N/A
#N/A #N/A
$ - $ -
#N/A #N/A
#N/A

$ - $ - $ - $ - $ -
4
H1 2022 H2 2022 H1 2023 H2 2023 Peak in Average District
Leave Blank
2 2 2 2
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

Liters
Fill here if known
-
-
PRODUCT AS DESIRED
0 $ 4,800 $ 6,300 $ 4,150 #N/A
0 $ 6,052 $ 7,552 $ 5,402 #N/A
$ 650 $ 850 $ 450 #N/A
292 $ 1,468 $ 2,418 $ 1,068 #N/A

596 $ 850 $ 1,800 $ 450 #N/A
360 $ 1,600 $ 1,600 $ 1,600 1
$ 650 $ 850 $ 450 #N/A
Units
Total Pre-existing in All Districts (FILL HERE) Remainder Required in All Districts
0 #N/A
0 #N/A
0 #N/A
MINUS EQUALS
0 #N/A
0 #N/A
0 0
0 #N/A
Solar On-Grid
Upper Price Lower Price Upper Price
#N/A #N/A #N/A
#N/A #N/A #N/A
$ - $ -
#N/A #N/A #N/A
#N/A
$ - $ - $ - $ - $ -
$ -
H1 2022 H2 2022 H1 2023 H2 2023 Peak in Average Fixed Site
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
Liters
Fill here if known
-
-
PRODUCT AS DESIRED
0 $ 3,300 $ 4,800 $ 2,650 #N/A
0 $ 3,616 $ 5,116 $ 2,966 #N/A
$ 650 $ 850 $ 450 #N/A
293 $ 1,399 $ 2,349 $ 999 #N/A

301 $ 1,810 $ 2,760 $ 1,410 #N/A
360 $ 1,600 $ 1,600 $ 1,600 1
$ 650 $ 850 $ 450 #N/A
Units
Total Pre-existing in All Fixed Sites (FILL HERE) Remainder Required in All Fixed Sites
0 #N/A
0 #N/A
0 #N/A
MINUS EQUALS
0 #N/A
0 #N/A
0 0
0 #N/A
Solar On-Grid
Upper Price Lower Price Upper Price
#N/A #N/A #N/A
#N/A #N/A #N/A
$ - $ -
#N/A #N/A #N/A
#N/A
$ - $ - $ - $ - $ -
$ -
International shipment per unit

Total WICR/WIFR #N/A $ 1,000
Total ILRs/SDDs/Ice pack freezers #N/A $ 150
Total UCC #N/A $ 150
Total RTMDs #N/A $ 150

H1 2022 H2 2022 H1 2023 H2 2023 Total

#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A




#N/A #N/A #N/A #N/A


CC BY-NC-SA 3.0 IGO licence.

ecks passed
###
B4. Dom
ADVAN
B4.1 Co
Logistic
Number
Vaccina
Rural Po
Populati
Surface
For pop
Half of
For pop
Typical distance between the central logistics hub and DM1 sites within the largest city
Note: This is a very simple model to estimate the average distance from the central store to fixed sites with cold storage
District-
Surface
Half of
Surface
Half of
DM2 sit
DM4 sit
Assumes that institutions (detention centers, nursing homes) will not be far from fixed sites by design
Cold ch
Volume
These are maximal volume need assumptions - i.e. that all shipments arrive and need storage but the vaccines not distributed domestically yet
Any
For each
By definition
Campai
Residen
i.e., where does the outreach team leave from?
Method
Volume
Volume
Populati
Populati
Populati
Populati
Refriger
Frozen (
Ultra-co
For version 2
Mainten
Walk-in
Ice-lined
Freezer
Solar D
No data on this available - assumption: 3x that of a non-UCC freezer (based on the approximate cost differences)
B4.1.1 C
Central Store Internat
International shipments per period can be also specified here for each period separately to optimize.
Volume
Cold sto
ogical note: The largest shipment size (plus buffer) is taken as the capacity required Volume
Refriger
Frozen (
Ultra-co
Volume
Fill here
If the volume of existing routine vaccines required is known, can be inputed here
Cold sto
WHO P
Source: GAVI [Covax-CCE-Budget-Template.xlsx], WHO PQS Catalogue [ http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/ ]
Source: PATH | No generator as electricity assumed to be reliable | Room air-conditioning for hot climates not included
NOTE: This part affects the capital expenditure calculationes NOT operational expenditures
ired in Central Store Total Pr
Refriger
Frozen (
Ultra-co
Remote
Use Low
Capital
Refriger
Frozen (
Ultra-co
Remote
Central
Value (f
Refriger
Frozen (
Ultra-co
Electric
For all the CCE equipment needed for COVID-19 vaccination, not just the newly purchased
B4.1.2 R
Assump
#of ice p
Average Region Shipmen
Shipments per period can be also specified here for each period separately to optimize.
Volume
Refriger
Frozen (
Ultra-co
Volume
Fill here
Cold sto
WHO P
Refriger
Frozen (
Ultra-co
Source: Cold chain costing assumptions 10 Nov 2020
Remote
uired in All Regions Total Re
Refriger
Frozen (
Ultra-co
Ice pack
Remote
Upper o
Capital
Refriger
Frozen (
Ultra-co
Ice pack
Remote
Total (A
Value (f
Refriger
Frozen (
Ultra-co
Ice pack
Electric
B4.1.3 D
Assump
#of ice p
Districts
Districts
Further 1 day subtracted for transport
Increase the frequency of shipments per period if any RED arrows seen
Average District Shipmen
Shipments per period can be also specified here for each period separately to optimize.
Volume
Cold sto
Refriger
Frozen (
UCC: Including vaccine doses bound for fixed sites which are transported direct from regional stores to fixed sites in 2-8C
Refriger
Volume
UCC: Including vaccine doses bound for fixed sites which are transported direct from regional stores to fixed sites in 2-8C
Volume
Fill here
Cold sto
Solar
Refriger
Frozen (
Remote
On-grid
Refriger
Frozen (
Ice pack
Remote
uired in All Districts Solar
Refriger
Frozen (
Remote
On-grid
Refriger
Frozen (
Ice pack
Remote
Upper o
Capital
Refriger
Frozen (
Only in on-grid districts
Remote
Total (A
Value (f
Solar
Frozen (
On-grid
Frozen (
Ice pack
Remote
Electric
B4.1.4 F
Assump
#of ice p
Fixed si
Fixed S
Average Fixed Site Shipmen
Volume
Cold sto
Refriger
Frozen (
Refriger
Volume
Fill here
Cold sto
Solar
Refriger
Frozen (
Remote
On-grid
Refriger
Frozen (
Ice pack
Remote
red in All Fixed Sites Solar
Refriger
Frozen (
Remote
On-grid
Refriger
Frozen (
Ice pack
Remote
Upper o
Capital
Refriger
Frozen (
Only in on-grid fixed sites
Remote
Total (A
Value (f
Solar
Frozen (
On-grid
Frozen (
Ice pack
Remote
Electric
B4.1.5 S
Central
Source: GAVI CCE Budget Template 2021-01-20
WIFR
Total U
Remote
Regions
ILR
ILFR or
Remote
Districts
SDD Re
SDD Fr
Districts
ILR
ILFR or
Fixed si
SDD Re
SDD Fr
Fixed S
ILR
ILFR or
Others
Remote
Ice pack
Total Ca
Value (f
Total co
Indicative only
Note: C
B4.1.6 C
Cold ch
Per Trip
Room te
Refriger
Frozen (
Ultra-co
Note this is MAX not SUM … assumption is that it is the same truck taking all the different types of vaccines to the same facility, and costs follow the most stri
Min vol
Refriger
Frozen (
UCC - dry ice shipper + dry ice
Cold ch
Per Trip
Room te
Refriger
Frozen (
Costing model would assume 2-8C below regional level - as per 5 days stability for BNT162b2. Frequent trips are needed - may be costly!
Min vol
Refriger
Frozen (
UCC treated as 2-8 C below regional stores
Cold ch
Per Trip
Assumes similar transport costs as personnel transport
NOTE: UCC vaccine doses destined for fixed sites will bypass districts
Per Vol
Refriger
Frozen (
Cold ch
Per Trip
Costing model would assume 2-8C below regional level - as per 5 days stability for BNT162b2. Frequent trips are needed - may be costly!
Per Vol
UCC Va
Dry ice
B4.2 Se
Security
Security
  
B5. Last Mile Service Delivery (excluding vaccines and related supplies)
Default number of days for teams to complete vaccinations within each time perio
MAX number of days for teams to complete vaccinations within each time period [DM 1-3] if
Default number of days for teams to complete vaccinations within each time pe
MAX number of days for teams to complete vaccinations within each time period [DM 1-3] for each
B5.0 Vaccine Courses to be Delivered - When, How, and How Many Is the payment mechanism used RBF?
Copied from B1 - EXPECTED not MAXIMUM uptake assumption | Not considering vaccine wastage rate
Work-based | Delivery Modality 1 No
Voluntary | Delivery Modality 1 No
Work-based | Delivery Modality 2 No
Voluntary | Delivery Modality 2 No
Delivery Modality 3 No
Delivery Modality 4 No
Total
B5.2 Last mile service delivery (input-based financing), excluding vaccines and related supplies (Medium-Variant)
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Local HRH (all Delivery Modalities)
Total Local Delivery Costs (excluding vaccines and related
supplies)
Last mile service delivery (input-based financing) cost per

person vaccinated
B5.2.1. Aggregates for resource mapping

HRH salaries (for new, non-redeployed vaccinators)
HRH wages (per diems)
Local Training and Deployment
HRH expenses
PPE
Local Demand Generation and Communications
Domestic travel for personnel
Last-mile transport
Local Data Management and Monitoring, Pharmacovigilance
- Capex
- Opex
Local Security
Additional Interventions
B5.2.2-A Human Resources (Medium-Variant)
Current vaccinators
New additional vaccinators per period
Total (across DMs) vaccinator hours
Total Vaccinator-Days
Total Vaccinator-Days - paid with per diems
Total (across DMs) vaccinator hours - paid with per diems
Cold boxes
Vaccine carriers
Redeployable HRH #N/A

Vaccinator FTEs
Redeployed Vaccinators (FTEs)
Non-Redeployed Vaccinators (FTEs)
Redeployed Vaccinators (Persons)
Non-Redeployed Vaccinators (Persons)

Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Local Human Resources

HRH wages (salaries for new, non-redeployed vaccinators)
HRH expenses
Total Reuseable PPEs
Total Daily Use PPEs
Vaccine Doses
B5.3-1 Delivery Modality 1 - Fixed sites with cold-storage ChAdOx1-S (COVIS2
4
Delivery Context
Initiation of service delivery
[HIDE]
[HIDE]
Sites to start with @ initiation of service delivery
[ADVANCED USERS] Additional Sites
New Sites
Cumulative Sites
Vaccinators per team

Number of Teams
Vaccinators for this DM
Total vaccine volume per period (liters)
Vaccinator Time Per Site Per Dose (hours)

Total Days Per Site Per Dose
Total Days Per Site Per Course
How long to vaccinate all sites (given # of teams)? (days)
Total Vaccinator Days 1
Total Vaccinator Hours 1
Total Site-Days
HRH Optimizer
Aim for teams to finish within the Time Period (minus days
weekends) 115
Override here to accelerate vaccination program days
Per Site
Per Person Eligible for Vaccination (Voluntary Uptake)
Per Person Eligible for Vaccination (Work-based Uptake)
Local Logistics
Mobile Team Type A (Solo) Per Team Per Day
Mobile Team Type B (Group) Per Team Per Day
Local Security
Security per Site per Day

Per Site
Per Site per Day
Per Site
Per Vaccinated Person
Vaccine Doses
B5.3-2 Delivery Modality 2: Campaigns at fixed sites (no cold stoChAdOx1-S (COVISHI 2
4
Delivery Context
Initiation of service delivery
[HIDE]
[HIDE]
Sites to start with @ initiation of service delivery
New Sites
Cumulative Sites
Domestic Travel to Sites this Period
Travelling Team Size

Number of Teams

Total Site-Days
HRH Optimizer
Teams spend one day per site 1
Number of teams | Finish sites within the Time Period (minus days
weekends) 115
Per Site
Local Logistics
Local Security

Per Team
Per Site per Day
Per Site
Vaccine Doses
B5.3-3 Delivery Modality 3: Residential Institution ChAdOx1-S (COVISHI 2
4
Delivery Context
[HIDE]
Current Sites this Period

Number of Teams

Total Site-Days
HRH Optimizer
Teams spend one day per site 1
Number of teams | Finish sites within the Time Period (minus days
weekends) 115
Per Site
Local Logistics
Local Security

Per Team
Per Site per Day
Per Site
Vaccine Doses
B5.3-4 Delivery Modality 4: Outreach and mobile Sites ChAdOx1-S (COVISHI 2
4
Delivery Context
[HIDE]
Current Sites this Period
Hard to access population which ... can come to the

vaccination delivery site / 'basecamp'
… need to be reached by mobile team Type A (single-person team)
… need to be reached by mobile team Type B (multi-person team)
Vaccinators per team (@Basecamp)

Vaccinators per team (Mobile A)
Vaccinators per team (Mobile B)
Total number of Basecamp Teams
Basecamp Teams per 'team of teams'
Mobile A Teams per 'team of teams'
Mobile B Teams per 'team of teams'
Cold boxes needed

Vaccine carriers needed
Vaccinator Time Per Site Per Dose (hours) - Basecamp

Vaccinator Time Per Site Per Dose (hours) - Mobile A
Vaccinator Time Per Site Per Dose (hours) - Mobile B
Total Days Per Site Per Dose - Basecamp

Total Days Per Site Per Dose - Mobile A
Total Days Per Site Per Dose - Mobile B
Total Days Per Site Per Course - Basecamp

Total Days Per Site Per Course - Mobile A
Total Days Per Site Per Course - Mobile B
(Max of the above)
How long to vaccinate areas in all sites (given # of teams)?

(days)
(days)
(days)
(Max of the above)

Total Site-Days
HRH Optimizer
Teams spend duration of 'cold life' per site 4
Mobile B : Mobile A ratio 1.50
2
Finish sites within this Time Period (minus weekends) 100 days
Per Site
Local Logistics
Local Security

Per Team
Per Site per Day
Per Site
 
Results Help
UCC acceleration factor 1

te vaccinations within each time period [DM 1-3] 115
within each time period [DM 1-3] if UCC is used 115
plete vaccinations within each time period [DM 4] 100
n each time period [DM 1-3] for each time period #N/A #N/A #N/A #N/A #N/A
t mechanism used RBF? HALF-YEARLY TIME PERIOD
cine wastage rate H1 2021 H2 2021 H1 2022 H2 2022 H1 2023
plies (Medium-Variant) #N/A #N/A #N/A #N/A #N/A

H1 2021 H2 2021 H1 2022 H2 2022 H1 2023


H1 2021 H2 2021 H1 2022 H2 2022 H1 2023
0 #N/A #N/A #N/A #N/A #N/A



Sites Time VolumeDays bet How many courses?

- 10 2.1 8 #N/A #N/A #N/A #N/A #N/A
14 10 6 H1 2021 H2 2021 H1 2022 H2 2022 H1 2023

- #N/A #N/A #N/A #N/A #N/A
- - - -



N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A



- 10 2.1 8 #N/A #N/A #N/A #N/A #N/A
14 10 6 H1 2021 H2 2021 H1 2022 H2 2022 H1 2023

- #N/A #N/A #N/A #N/A #N/A
- - - -



N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A
#N/A


#N/A 10 2.1 8 #N/A #N/A #N/A #N/A #N/A
14 10 6 H1 2021 H2 2021 H1 2022 H2 2022 H1 2023





N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A
#N/A


- 10 2.1 8 #N/A #N/A #N/A #N/A #N/A
14 10 6 H1 2021 H2 2021 H1 2022 H2 2022 H1 2023

0 0 0 0 0
- - - - -
- - - - -

0 0 0 0 0
1 1 1 1 1
2 2 2 2 2
0 0 0 0 0
1 1 1 1 1
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0.0 0.0 0.0 0.0 0.0

0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -

- - - - -
Basecamp (per site) 0 0 0 0 0

Mobile A (per site) 0 0 0 0 0
Mobile B (per site) 0 0 0 0 0
Number of team of teams 0 0 0 0 0

N/A N/A N/A N/A N/A


#N/A

#N/A
H2 2023 Total
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
H2 2023 Total
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
H2 2023 Total Max
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
-
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Total
#N/A #N/A
H2 2023 Total Max
#N/A
#N/A
#N/A
#N/A
-
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
N/A $ -
N/A $ -
#N/A #N/A
N/A $ -
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Total
#N/A #N/A
H2 2023 Total Max
#N/A
#N/A
#N/A
#N/A
-
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A #N/A
#N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
N/A $ -
N/A $ -
#N/A #N/A
N/A $ -
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Total
#N/A #N/A
H2 2023 Total Max
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A #N/A
#N/A
#N/A
#N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
#N/A
#N/A #N/A
N/A $ -
#N/A #N/A
N/A $ -
N/A $ -
#N/A #N/A
N/A $ -
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Total
#N/A #N/A
H2 2023 Total Max
#N/A
0
-
-
#N/A
#N/A
#N/A #N/A
#N/A #N/A
0
1
2
0 -
1
0
0
#N/A
0 -
0 -
#N/A
0.0
0.0
0.0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- - -
#N/A #N/A
#N/A #N/A
- -
0
0
0
0
#N/A #N/A
#N/A #N/A
N/A $ -
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Effectively a 4-day work week (either 2 sites x 2 days in a week or 1 site x 4 days in a week depending on 'cold life'
Notes
FYI only - taken from Sheet B1
Notes
Last mile service delivery (input-based financing) is the 'default'
FYI Only
Decomissioned vaccinators would need to be retrained, re-PPE'ed
Travel from nearest fixed site to compaign site

Travel from nearest fixed site to each institution
Travel from nearest fixed site to each remote site (to replenish vaccines et al
For vaccinators newly recruited rather than redeployed, this item allows the inclusion of their salary
Notes
Note that sites are treated as equal-sized 'averages'

Trigger ONCE (with "1") to indicate start
Triggered
Vaccinations going on this period?
Whole Number; Leave blank if unsure
One team goes to one site; Optimize size of team

In DM1 … it should equal the number of sites
Volume of the whole tranche of vaccines at delivery
Average (mean) sized sites

Quantized-up based on facilities
In case more than one dose needed
MAX should be number of days per period; disregarding weekends and hols
Not quantized up - this is for supplementary incentive
Zero (this is a fixed site)

Consider adjustment for weekends

DEVELOP LATER IF NEEDED
Notes

Trigger ONCE (with "1") to indicate start
Triggered
Whole Number; Leave blank if unsure
One team per site

This should be 1

How long before the ice melts?
Consider travel time and breaks

Consider adjustment for weekends [TODO]

Notes

One team per site

Optimize these

This should be 1
Consider travel time and breaks


Notes

For DM4 - mobile sites in remote areas will be covered once and then move on
Optimize these
Mobile Team A by definition one-person team
By defintion
NOT
Optimize these
This should be just within the 'cold life'

One team, and n team members

One team member, and n teams
Range from 2-4; The outreach weekly schedule is force-synced to this even if it may be possible to finish a site faster
Effectively a 4-day work week (either 2 sites x 2 days in a week or 1 site x 4 days in a week depending on 'cold life'

B5.4 Variance Analysis
H1 2021
Upper Variant (Total) #N/A
Lower Variant (Total #N/A
Medium Variant (Total) #N/A
Additional Costs for Upper Variant #N/A
Reduced Costs for Lower Variant #N/A

B5.2-B (Upper-Variant) #N/A
H1 2021
Local HRH (all Delivery Modalities) #N/A
Total Local Delivery Costs (excluding vaccines and
related supplies) #N/A
Last mile service delivery (input-based financing) cost

per person vaccinated #N/A
HRH salaries (for new, non-redeployed vaccinators) #N/A

HRH wages (per diems) #N/A
Local Training and Deployment #N/A
HRH expenses #N/A
PPE #N/A
Local Demand Generation and Communications #N/A
Domestic travel for personnel #N/A
Last-mile transport #N/A
Local Data Management and Monitoring,
Pharmacovigilance - Capex #N/A
Pharmacovigilance - Opex #N/A
Local Security #N/A
Additional Interventions #N/A
B5.2.2-B (Upper-Variant)
H1 2021
Current vaccinators #N/A
New additional vaccinators per period #N/A
Total (across DMs) vaccinator hours #N/A
Total Vaccinator-Days #N/A
Total Vaccinator-Days - paid with per diems #N/A
Total (across DMs) vaccinator hours - paid with per diems #N/A
Cold boxes
Vaccine carriers
Redeployable HRH
Vaccinator FTEs #N/A
Redeployed Vaccinators (FTEs) #N/A
Non-Redeployed Vaccinators (FTEs) #N/A


HRH wages (salaries for new, non-redeployed vaccinators) #N/A
HRH expenses #N/A
Total Reuseable PPEs #N/A
Total Daily Use PPEs #N/A
#N/A
12.5 #N/A
H1 2021
Delivery Context
Initiation of service delivery #N/A
- #N/A
[HIDE] #N/A
Sites to start with @ initiation of service delivery #N/A
New Sites #N/A
Cumulative Sites #N/A
Vaccinators per team #N/A

Number of Teams #N/A
Vaccinators for this DM #N/A
Total vaccine volume per period (liters) #N/A
Vaccinator Time Per Site Per Dose (hours) #N/A

Total Days Per Site Per Dose #N/A
Total Days Per Site Per Course #N/A
How long to vaccinate all sites (given # of teams)? (days) #N/A
Total Vaccinator Days #N/A
Total Vaccinator Hours #N/A
Total Site-Days #N/A
HRH Optimizer
Aim for teams to finish within the Time Period (minus #N/A
weekends)

Per Site #N/A
Per Person Eligible for Vaccination (Voluntary Uptake) #N/A
Per Person Eligible for Vaccination (Work-based Uptake) #N/A
Local Logistics
Mobile Team Type A (Solo) Per Team Per Day N/A
Mobile Team Type B (Group) Per Team Per Day N/A
Local Security
Security per Site per Day #N/A
Security per Mobile Team per Day N/A

Per Site #N/A
Per Site per Day #N/A
Per Site #N/A
Per Vaccinated Person #N/A
12.5 2.1 8 #N/A

H1 2021
Delivery Context
- #N/A
[HIDE] #N/A
New Sites #N/A
Domestic Travel to Sites this Period #N/A
Travelling Team Size #N/A


HRH Optimizer
Teams spend one day per site #N/A
Number of teams | Finish sites within the Time Period (minus #N/A
weekends)

Per Site #N/A
Local Logistics
Local Security

Per Team #N/A
Per Site #N/A
12.5 2.1 8 #N/A

H1 2021
Delivery Context
[HIDE] #N/A
Current Sites this Period #N/A


HRH Optimizer
weekends)

Per Site #N/A
Per Person Eligible for Vaccination (Voluntary Uptake) N/A
Local Logistics
Local Security

Per Team #N/A
Per Site #N/A
12.5 2.1 8 #N/A

H1 2021
Delivery Context
[HIDE] #N/A
Current Sites this Period 0
Domestic Travel to Sites this Period -
Travelling Team Size -
Hard to access population which ... can come to the #N/A

… need to be reached by mobile team Type A (single-person team) #N/A
… need to be reached by mobile team Type B (multi-person team) #N/A
Vaccinators per team (@Basecamp) 0

Vaccinators per team (Mobile A) 1
Vaccinators per team (Mobile B) 2
Total number of Basecamp Teams 0
Basecamp Teams per 'team of teams' 1
Mobile A Teams per 'team of teams' 0
Mobile B Teams per 'team of teams' 0
Cold boxes needed 0

Vaccine carriers needed 0
Vaccinator Time Per Site Per Dose (hours) - Basecamp 0.0

Vaccinator Time Per Site Per Dose (hours) - Mobile A 0.0
Vaccinator Time Per Site Per Dose (hours) - Mobile B 0.0
Total Days Per Site Per Dose - Basecamp -

Total Days Per Site Per Dose - Mobile A -
Total Days Per Site Per Dose - Mobile B -
Total Days Per Site Per Course - Basecamp -

Total Days Per Site Per Course - Mobile A -
Total Days Per Site Per Course - Mobile B -
(Max of the above) -
How long to vaccinate areas in all sites (given # of teams)? -

(days)
(days)
(days)

Total Site-Days -
HRH Optimizer
Mobile B : Mobile A ratio 0
0
Finish sites within this Time Period (minus weekends) 0

Per Site #N/A
Per Person Eligible for Vaccination (Work-based Uptake) N/A
Local Logistics
Mobile Team Type A (Solo) Per Team Per Day #N/A
Mobile Team Type B (Group) Per Team Per Day #N/A
Local Security
Security per Mobile Team per Day #N/A

Per Team #N/A
Per Site #N/A
H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total




H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

- - - - -



N/A N/A N/A N/A N/A $ -





H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

- - - - -





#N/A


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total







#N/A


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

0 0 0 0 0
- - - - -
- - - - -

#N/A
0 0 0 0 0
1 1 1 1 1
2 2 2 2 2
0 0 0 0 0
1 1 1 1 1
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0.0 0.0 0.0 0.0 0.0

0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -

- - - - - -
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0



#N/A

Percent
#N/A
#N/A
B5.2-C (Lower-Variant) #N/A
H1 2021
Local HRH (all Delivery Modalities) #N/A
Total Local Delivery Costs (excluding vaccines and
related supplies) #N/A
Last mile service delivery (input-based financing) cost

per person vaccinated #N/A
HRH salaries (for new, non-redeployed vaccinators) #N/A

HRH expenses #N/A
PPE #N/A
Local Demand Generation and Communications #N/A
Domestic travel for personnel #N/A
Last-mile transport #N/A
Pharmacovigilance - Capex #N/A
Pharmacovigilance - Opex #N/A
Local Security #N/A
Additional Interventions #N/A
B5.2.2-C (Lower-Variant)
Max H1 2021
#N/A Current vaccinators #N/A
New additional vaccinators per period #N/A
Total (across DMs) vaccinator hours #N/A
Total Vaccinator-Days #N/A
Total Vaccinator-Days - paid with per diems #N/A
Total (across DMs) vaccinator hours - paid with per diems #N/A
#N/A Cold boxes
- Vaccine carriers
Redeployable HRH
Vaccinator FTEs #N/A
Redeployed Vaccinators (FTEs) #N/A
Non-Redeployed Vaccinators (FTEs) #N/A


HRH wages (salaries for new, non-redeployed vaccinators) #N/A
HRH expenses #N/A
Total Reuseable PPEs #N/A
Total Daily Use PPEs #N/A
#N/A
7.5 #N/A
Max H1 2021

- #N/A
[HIDE] #N/A
New Sites #N/A


#N/A How long to vaccinate all sites (given # of teams)? (days) #N/A
HRH Optimizer
Aim for teams to finish within the Time Period (minus #N/A
weekends)

(same) Per Site #N/A
(same) Per Person Eligible for Vaccination (Voluntary Uptake) #N/A
(same) Per Person Eligible for Vaccination (Work-based Uptake) #N/A
Local Logistics
Local Security

Per Site #N/A
(same) Per Vaccinated Person #N/A
7.5 2.1 8 #N/A

Max H1 2021
Delivery Context
- #N/A
[HIDE] #N/A
New Sites #N/A


#N/A Number of Teams #N/A

HRH Optimizer
weekends)

Local Logistics
Local Security

Per Team #N/A
7.5 2.1 8 #N/A

Max H1 2021
Delivery Context
[HIDE] #N/A
Current Sites this Period #N/A

#N/A Number of Teams #N/A

#N/A Total Days Per Site Per Dose #N/A
HRH Optimizer
weekends)

(same) Per Person Eligible for Vaccination (Voluntary Uptake) N/A
Local Logistics
Local Security

Per Team #N/A
7.5 2.1 8 #N/A

Max H1 2021
Delivery Context
[HIDE] #N/A
Current Sites this Period 0
Domestic Travel to Sites this Period -
Travelling Team Size -
Hard to access population which ... can come to the #N/A

… need to be reached by mobile team Type A (single-person team) #N/A
… need to be reached by mobile team Type B (multi-person team) #N/A
Vaccinators per team (@Basecamp) 0

Vaccinators per team (Mobile A) 1
Vaccinators per team (Mobile B) 2
- Total number of Basecamp Teams 0
Basecamp Teams per 'team of teams' 1
Mobile A Teams per 'team of teams' 0
Mobile B Teams per 'team of teams' 0
- Cold boxes needed 0

- Vaccine carriers needed 0
Vaccinator Time Per Site Per Dose (hours) - Basecamp 0.0

Vaccinator Time Per Site Per Dose (hours) - Mobile A 0.0
Vaccinator Time Per Site Per Dose (hours) - Mobile B 0.0
Total Days Per Site Per Dose - Basecamp -

Total Days Per Site Per Dose - Mobile A -
Total Days Per Site Per Dose - Mobile B -
Total Days Per Site Per Course - Basecamp -

Total Days Per Site Per Course - Mobile A -
Total Days Per Site Per Course - Mobile B -

(days)
(days)
(days)
- (Max of the above) -

Total Site-Days -
HRH Optimizer
Mobile B : Mobile A ratio 0
0
Finish sites within this Time Period (minus weekends) 0

(same) Per Person Eligible for Vaccination (Work-based Uptake) N/A
Local Logistics
Mobile Team Type A (Solo) Per Team Per Day #N/A
Mobile Team Type B (Group) Per Team Per Day #N/A
Local Security
Security per Mobile Team per Day #N/A

Per Team #N/A
H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total




H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

- - - - -








H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

- - - - -





#N/A


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total







#N/A


H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 Total

0 0 0 0 0
- - - - -
- - - - -

#N/A
0 0 0 0 0
1 1 1 1 1
2 2 2 2 2
0 0 0 0 0
1 1 1 1 1
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0.0 0.0 0.0 0.0 0.0

0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -
- - - - - -

- - - - - -
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0



#N/A

Max
#N/A
#N/A
-
Max
#N/A
Max
#N/A
#N/A
Max
#N/A
#N/A
#N/A
Max
-
-
-
NAVIGATION BAR:   
Menu Next Page Help
R1. Output Reports and Visualizations
Last Update (Vaccine database):
Logic Checks in Sheet A2

Logic Checks in Sheet A3
Logic Checks in Sheet B1
Supply-demand balanced?
UCC-related errors in Sheet B4
R1.1 Total Costs, over time
Note: Total costs estimated using this costing platform, based on user-specified assumptions on target population prioritization,
Medium variant estimates use the vaccination time per dose specified in the vaccine database (default = 10 mins), and the upper
The costs for vaccination included in this total are operational costs, selected capital costs of interest to partners, and central-lev
Total Costs
Grand Total (USD) - Medium Variant
Upper Variant
Lower Variant
per dose (wastage assumption applied)

per fully immunized person (assumes perfect uptake of 2nd dose; medium variant)
(medium variant) …. cumulative
(upper variant) …. cumulative
(lower variant) …. cumulative
Grand Total (LCU)
Total Costs
Total Costs
$12
$10
$8
$6 Grand Total (USD) -

Medium Variant
$4
Upper Variant
$2
Lower Variant
$-
21 21 22 22 23 23
20 20 20 20 20 20
1 2 1 2 1 2
H H H H H H
$4
Upper Variant
$2
Lower Variant
$-
21 21 22 22 23 23
20 20 20 20 20 20
1 2 1 2 1 2
H H H H H H
Total Costs (excluding vaccines)

Total Costs (excluding vaccines)
$12
$10
$8
$6 Grand Total (USD) -

Medium Variant
$4
Upper Variant
$2
$- Lower Variant
21 21 22 02
2
02
3
02
3
20 20 20 2 2 2
1 2 1 2 1 2
H H H H H H
R1.2 Cost Breakdown, by Category
ReferItem
R2.1 - 1 Cross-cutting Technical Assistance (TA) for Planning, Coordination and Delivery
R2.1 - 2 Vaccine Doses and Related Devices & Supplies
R2.1 - 3 Vaccinators
R2.1 - 4 Vaccination Delivery
R2.1 - 5 Cold Chain
R2.1 - 6 Data Management, Monitoring & Evaluation, and Oversight
R2.1 - 7 Vaccine Safety Surveillance and Injection Safety
R2.1 - 8 Demand Generation and Communications
R2.1 - 9 Protecting Essential Health Services and Health Systems Strengthening
per fully immunized person (assumes perfect uptake of 2nd dose) excluding vaccines
per dose excluding vaccines (wastage assumption applied)
Cost Breakdown
Cost Breakdown
Cross-cutting Technical Assistance Vaccine Doses and Related Devices

(TA) for Planning, Coordination & Supplies
and Delivery
Vaccinators Vaccination Delivery
Cold Chain Data Management, Monitoring &
Evaluation, and Oversight
Vaccine Safety Surveillance and Demand Generation and
Injection Safety Communications
Protecting Essential Health Services
and Health Systems Strengthening
R1.3 How fast? (Medium Variant)
R1.3.1 Days within a period (considering weekends), concurrent delivery modality teams
Note: This blue bars in section displays the time (in days) per time period of 180 days, that will be needed for the vaccination ca
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Population Vaccinated, given expected uptake rates

Cumulative total (percent of 2023 population)
Cumulative vaccine supply (percent of 2020 population) excluding wastage
By End of the
Cumulative Period Expected to be Vaccinated,
Population
% of 2023 Population
Cumulative Population Expected to be Vaccinated,
% of 2023 Population
100%
80%
60%
40%
20%
0%
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
By End of the Period
Cumulative total (percent of 2023 population)

Cumulative vaccine supply (percent of 2020 population) excluding wastage
R1.3.1.1 Outreach Efficiency

Note: For countries where outreach costs are high, a universal vaccination strategy (covering all ages, high-risk and low-risk po
(repeated visits to outreach sites) is estimated here.
To specify a universal vaccination strategy, review the prioritization in B1 and specify the exact same percentage prioritization
Inefficient (non-universal) strategy for DM4
R1.3.2 Human Resources Implications and Impact

Note: To estimate the robustness of the estimates, especially with regard to variation in time required to vaccinate, upper, mediu
The implications of these variants on the surge demand for vaccinators can be visualized below; and the context for this demand
For countries where the health workforce is relatively small and already fully occupied with providing essential services, redepl
Select the HRH Model Variant:
2 Medium Variant
FTEs = Full-time equvalents
Current Vaccinators (Not Full-Time Equivalents)
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Total Current Vaccinators
New vaccinators (Persons, not FTEs) for training
Maximum/peak number of vaccinators
Vaccinator-Days
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Current Vaccinators (Full-Time Equivalents)

Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Total Full-time Equivalents
R1.3.2.1: Impact relative to HRH supply

IMPACT - as % of HRH Supply
Current Vaccinators (Not Full-Time Equivalents)
Current Vaccinators (Full-Time Equivalents)
Current Vaccinators (Full-Time Equivalents) - IMPACT - as % of HRH Supply
R1.3.2.2: Impact - redeployment vs newly inducted vaccinators (based on FTEs)
IMPACT - Redeployment (FTEs)
HRH Maximum deployment
Redeployable Vaccinators
Redeployed Vaccinators (by FTEs)

Non-Redeployed Vaccinators (by FTEs)
Redeployed Vaccinators (by person)

Non-Redeployed Vaccinators (by person)
Current Vaccinators (FTEs) - Medium Variant

12
10
8 Delivery Modality 4
Delivery Modality 3
Delivery Modality 1
4
2
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
Delivery Modality 1
4
2
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
Impact on Health System - Medium Variant

12 1200.0%
10 1000.0%
New vaccinators (Persons, not

8 800.0% FTEs) for training
Current Vaccinators (Full-Time
6 600.0% Equivalents) - IMPACT - as % of
HRH Supply
4 400.0%
2 200.0%
- 0.0%
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
R1.3.2.3 Human Resources - Supplementary metrics for optimization and diagnostics - Medium Variant
Vaccinator-Hours
Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Total Vaccinator-Hours
Mean vaccinator-days per current vaccinator per period

Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
All delivery modalities
Mean vaccinator-days per current vaccinator (hourly calc)

Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Mean hours per day

Delivery Modality 1
Delivery Modality 2
Delivery Modality 3
Delivery Modality 4
Vaccinator Days -Medium Variant

12
10
Vaccinator Days -Medium Variant
12
10
Delivery Modality 3
Delivery Modality 1
4
2
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period

Help
26 February 2021 Please note that default unit prices, incl. for vaccine related supplies, are unstable due to market
Note: CVIC v2.1 requires Microsoft Excel 2016 (v16.0) or newer

Logic checks failed - Errors = 22 Go to Sheet A2 to fix logic checks
Logic checks failed - Errors = 20 Go to Sheet A3 to fix logic checks
Logic checks failed - Errors = 1 Go to Sheet B1 to fix logic checks
Logic checks failed - Errors = Go to Sheet B1 to fix logic checks
Logic checks passed Go to sheet B4 to fix logic checks
ed assumptions on target population prioritization, delivery parameters, and unit costs are provided here.
vaccine database (default = 10 mins), and the upper and lower variants use vaccination times longer and shorter than the medium variant, by a user-sp
capital costs of interest to partners, and central-level investments and development costs for activities described in the VIRAT-VRAF 2.0 and NDVP
Total H1 2021 H2 2021

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A
#N/A #N/A
$ 2.00 #N/A #N/A
#N/A - #N/A #N/A
Cumulative Costs
$12
$10
Grand Total (USD) - $8 Grand Total (USD) - Medium

Medium Variant Variant
Upper Variant
$6
Upper Variant Lower Variant
Lower Variant $4
23
$2
$-
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Upper Variant
$6
Lower Variant $4
23
$2
$-
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
#N/A Cumulative Costs (excluding

#N/A vaccines) #N/A
#N/A #N/A #N/A
$12 #N/A #N/A #N/A
$10
Grand Total (USD) - $8 #N/A Grand Total (USD) - Medium

#N/A
Medium Variant #N/A Variant #N/A
#N/A Upper Variant
#N/A
$6
Lower Variant $4
23
$2
$-
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Total H1 2021 H2 2021

#N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
Cost Breadown (in H1 2021, inc. central costs)
cine Doses and Related Devices Cross-cutting Technical Assistance Vaccine Doses and Related Devices
upplies (TA) for Planning, Coordination & Supplies
and Delivery
cination Delivery Vaccinators Vaccination Delivery
a Management, Monitoring & Cold Chain Data Management, Monitoring &
luation, and Oversight Evaluation, and Oversight
mand Generation and Vaccine Safety Surveillance and Demand Generation and
mmunications Injection Safety Communications
Protecting Essential Health Services
and Health Systems Strengthening
modality teams Period (days) =
180 days, that will be needed for the vaccination campaign.
H1 2021 H2 2021
(medium variant) #N/A #N/A
(medium variant) 0 0
(upper variant) #N/A #N/A

(upper variant) 0 0
(lower variant) #N/A #N/A

(lower variant) 0 0
#N/A #N/A
#N/A #N/A #N/A
3.0% 20.0%
accinated,
H1 2023 H2 2023
excluding wastage
ategy (covering all ages, high-risk and low-risk populations at the same time) in remote rural outreach areas can be considered. Doing so will save co
nd specify the exact same percentage prioritization pattern for all target population groups who are hard-to-reach (delivery modality 4).
Repeated visits to outreach sites
0 <-- Adopting a universal vaccination strategy rather than a high-risk only first strategy will save on n n
ariation in time required to vaccinate, upper, medium, and lower variants can be specified here.
e visualized below; and the context for this demand relative to existing core HRH supply are also estimated.
y occupied with providing essential services, redeployment of vaccinators may result in compromises to pre-existing essential services. Hence, newly r
Suggestion / Default: Current Vaccinators (FTEs) -
Medium Variant 0 Current Vaccinators (FTEs) - Med
Peak % H1 2021 H2 2021

#N/A #N/A
### #N/A #N/A
#N/A #N/A
### #N/A #N/A
#N/A #N/A
### #N/A #N/A
#N/A #N/A
### #N/A #N/A
#N/A ### #N/A #N/A
### #N/A #N/A
#N/A ###
Total H1 2021 H2 2021

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
Peak H1 2021 H2 2021

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
Peak H1 2021 H2 2021

#N/A #N/A #N/A
#N/A #N/A #N/A
ed on FTEs)
#N/A
#N/A
H1 2021 H2 2021
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
Variant Vaccinator Redeployment (FTEs) -Medium Variant

12
10
Delivery Modality 3 Non-Redeployed Vaccinators (by
Delivery Modality 2 6 FTEs)
Delivery Modality 1 Redeployed Vaccinators (by FTEs)
4
2
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
Delivery Modality 2 6 FTEs)
Delivery Modality 1 Redeployed Vaccinators (by FTEs)
4
2
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
ariant Vaccinator Redeployment (Persons) - Medium Variant

12
10
ew vaccinators (Persons, not 8

Non-Redeployed Vaccinators (by
TEs) for training
6 person)
urrent Vaccinators (Full-Time
Redeployed Vaccinators (by
quivalents) - IMPACT - as % of
4 person)
RH Supply
0
H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
n and diagnostics - Medium Variant

Total H1 2021 H2 2021
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2021 H2 2021
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
H1 2021 H2 2021
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
Total H1 2021 H2 2021

#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
t Vaccinator Hours - Medium Variant

12
10
Delivery Modality 4 8 Delivery Modality 4

t Vaccinator Hours - Medium Variant
12
10

Delivery Modality 3 Delivery Modality 3
Delivery Modality 1 Delivery Modality 1
4
Total Vaccinator-Days Total Vaccinator-Hours
2
0
3 H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023
Period
(UNICEF), 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
2021.2
upplies, are unstable due to market conditions and vaccine specifications are preliminary and indicative only. SUBJECT TO CHANGE.
han the medium variant, by a user-specified [A2.3] duration (default is 2.5 mins longer and 2.5 mins shorter).
in the VIRAT-VRAF 2.0 and NDVP. Details of the costs included are disaggregated in R2.
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
rand Total (USD) - Medium

ariant
pper Variant
ower Variant
pper Variant
ower Variant
s) #N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
rand Total (USD) - Medium #N/A #N/A #N/A

ariant #N/A #N/A #N/A
pper Variant #N/A #N/A #N/A
ower Variant
H1 2022 H2 2022 H1 2023
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
costs)
e Doses and Related Devices

lies
ation Delivery
anagement, Monitoring &
ion, and Oversight
d Generation and
unications
180
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
0 0 0
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
0 0 0
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
0 0 0
#N/A #N/A #N/A

#N/A #N/A #N/A
20.0% 20.0% 20.0%
be considered. Doing so will save costs arising for repeated visits to the same outreach site to vaccinate different sub-populations. The savings
(delivery modality 4).
risk only first strategy will save on n number of repeated visits to outreach sites
ing essential services. Hence, newly recruited vaccinators, where possible, should be considered.
Vaccinator Redeployment (FTEs) Vaccinator Days - Impact on Health System -
Vaccinator Redeployment (FTEs) Vaccinator Days -Medium VariantImpact on Health System - Mediu
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A

#N/A #N/A #N/A
Variant
edeployed Vaccinators (by
oyed Vaccinators (by FTEs)

oyed Vaccinators (by FTEs)
m Variant
Redeployed Vaccinators (by

n)
ployed Vaccinators (by
n)
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
H1 2022 H2 2022 H1 2023

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
Delivery Modality 4
Delivery Modality 4
Delivery Modality 3
Delivery Modality 2
Delivery Modality 1
Total Vaccinator-Hours
GO licence.
dicative only. SUBJECT TO CHANGE.
orter).
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
Cumulative Costs
Cumulative Costs (excluding vaccines)
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
Cost Breadown (in H1 2021, inc. ce

H2 2023
#N/A
#N/A
#N/A
0
#N/A
#N/A
#N/A
0
#N/A
#N/A
#N/A
0
#N/A
#N/A
20.0%
different sub-populations. The savings

Vaccinator Redeployment (Persons) -
Vaccinator Redeployment (Persons) - Medium Variant
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
H2 2023
#N/A
#N/A
#N/A
#N/A
#N/A
Vaccinator Hours - Medium Variant

xcluding vaccines)
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
Per course; Assumes no partially vaccinated persons

Per dose (including wasted doses)
ment (Persons) -
ment (Persons) - Medium Variant
Note that DM1 vaccinators are assumed to be based statically in those fixed sites - not part of the pool of vaccinators going to other
130
i.e., newly inducted vaccinator workforce, in order to preserve existing services
i.e., newly inducted vaccinator workforce, in order to preserve existing services

Time spent on vaccination alone - no travel, setup, etc.
Each vaccinator works this number of days per time period
Each vaccinator works this number of days per time period (based on an hourly calculation)
Mean hours spent vaccinating per day worked
Medium Variant


NAVIGATION BAR: Menu
Next
Page
R2. Resource Mapping - Domestic, Partner, and Consortium Mapping

R2.0 Summary (Medium Variant)
R2.0.1 Financing Source

Instructions: This resource mapping section allows users to map out various cost components (listed in R2.1) to financing sources. Fi
Some partners are listed below and additional names of partners or partner consortia relevant to the country can be added in the beige
After the names of partners and or consortia of partners have been listed, please 'map' each cost item [Column K] to a financing sourc
is no interest to finance such an item. Please do not change the name of the partner/consortia once the allocation in Column K has be
1 Domestic
1 GAVI
1 WB
1 IADB
1 ADB
1 AfDB
1 Consortium A: e.g. GAVI/WB
1 Consortium B
1 Consortium C
1 Single-Donor A
1 Donor B
1 Donor C
1 Donor D
1 Donor E
Total Cost Allocated / Mapped
Total Cost Unallocated (Financing Gap)
R2.0.2 Budgetary Unit / Financing Agent

Instructions: This resource mapping section allows users to map out various cost components (listed in R2.1) to a budgetary unit, thro
such a role.
Additional names of budgetary units / financing agents relevant to the country can be added in the beige cells below.
After the names of budgetary units / financing agents have been listed, please 'map' each cost item [Column L] to a unit / agent to vie
the allocation in Column L has been performed.
2 Ministry of Health
2 Budgetary Entity A
2 Budgetary Entity B
2 Budgetary Entity C
2 Budgetary Entity D
2 Budgetary Entity E
2 Budgetary Entity F
2 Budgetary Entity G
2 Budgetary Entity H
2 Budgetary Entity I
Total Cost Allocated / Mapped
R2.0.3 Health Financing Benchmarking
Current Health Expenditure (nominal US$)

2 General Government Health Expenditure (nominal US$)
2 Domestic General Government Health Expenditure (nominal US$)
2 Domestic General Government Health Expenditure + Development Aid for Health [GGHED + DAH] (nominal US$)
2 External Health Expenditure (nominal US$)
2 Health Capital Expenditure (nominal US$)
2 Total Expediture on Vaccines from all sources (US$) - average of 2015-2019 - JRF (6520)
2 General Government Expenditure (nominal US$) 2021p
Covid-19 Vaccination Costs

Domestic Total (USD)
External Total (USD)
Financing through MOH (USD)
Capital Expenditure (USD)
Covid-19 vaccination benchmarking against recent health expenditures:

Additional to existing financing (vaccination financing added to the denominator)
Grand Total as % of GGE
Grand Total as % of 2018 GGHED +DAH
Grand Total as % of Vaccination Financing
Domestic as % of 2018 GGHED
External as % of 2018 EXT
Capital Expenditures as % of 2018 HK
R2.1 Common Costing Categories for Covid-19 Immunization (NDVP 2.0)
R2.1 - 1. Cross-cutting Technical Assistance (TA) for Planning, Coordination and Delivery
CVIC Estimates
2 OVERRIDE HERE if alternative costing used for section above
1.1 Planning and coordination

1.2 Costing, budgeting, and financing
1.3 Regulatory preparedness
1.4 Identification of target population and prioritization
1.5 Covid-19 disease surveillance
1.6 Service delivery
1.7 Vaccine procurement, cold chain, logistics, and infrastructure
R2.1 - 2. Vaccine Doses and Related Devices & Supplies
Demand-based vaccine dose cost estimate - based on final price, target population, vaccine wastage, and expected uptake - FYI only
Total
IMPORTANT: For adequate costing estimates, ensure vaccine supply and demand is balanced [B1.2] - i.e., all
half-year periods show "OK" in Green
IMPORTANT: These are fully loaded vaccine doses (i.e., vaccine-related devices, supplies, and shipping are included)
AMC92 fully-subsidized doses
2.1 Vaccine doses and vaccine-related devices & supplies (fully loaded)
CVIC Estimates
AMC92 fully-subsidized courses (quantity)
IMPORTANT: These are standalone vaccine doses (i.e., vaccine-related devices, supplies, and shipping are costed separately)
AMC: Covax cost sharing for additional doses
CPA: Upfront payment
CPA: Remainder
OPA: Upfront payment
OPA: Risk-sharing guarantee
OPA: Remainder
Non-COVAX vaccine supply [taken from A2.6.2]
International Shipping (Vaccine doses only; Not equipment or vaccine related supplies)
Adjustment for Covax fully loaded doses [ESTIMATE ONLY]
2.2 Vaccine doses
CVIC Estimates
Vaccine-related Supplies & Devices (excluding waste management [4.2])

2.3 Vaccine-related supplies and devices
CVIC Estimates
R2.1 - 3. Vaccinators
Please note this whole section uses Medium Variant
3.1 Technical assistance
CVIC Estimates
Training & Supervision [Other activities]

3.2 Vaccinator training and supervision
CVIC Estimates

HRH expenses
HRH salaries (for new, non-redeployed vaccinators)
3.3 Vaccinator compensation
CVIC Estimates
3.4 Other
CVIC Estimates
R2.1 - 4. Vaccination Delivery

Last-mile transport
4.1 Logistics and transportation (excluding cold chain)
CVIC Estimates
Waste Management
4.2 Waste management
CVIC Estimates
4.3 Personal protective equipment (PPE)

CVIC Estimates
Security (Technical Assistance)

Security at central store
Security during vaccine transport from central to regional
Local Security
4.4 Security
CVIC Estimates
R2.1 - 5. Cold Chain
Central Cold Storage - Capital Expenditures

Total (All Regions) Cold Storage - Capital Expenditures
Total (All Districts) Cold Storage - Capital Expenditures
Total (All Fixed Sites) Cold Storage - Capital Expenditures
International shipment
Cold boxes, vaccine carriers, and ice packs
5.1 Capital expenditure
CVIC Estimates
Central Cold Storage - Operational Expenditures

Total (All Regions) Cold Storage - Operational Expenditures
Total (All Districts) Cold Storage - Operational Expenditures
Total (All Fixed Sites) Cold Storage - Operational Expenditures
Cold-chain domestic transportation
5.2 Operational expenditure
CVIC Estimates
R2.1 - 6. Data Management, Monitoring & Evaluation, and Oversight

Technical Assistance
Local Data Management and Monitoring, Pharmacovigilance - Capex
CVIC Estimates
A4.1-G Central Operational Expenditures
Local Data Management and Monitoring, Pharmacovigilance - Opex
Vaccination cards
6.2 Operational expenditures

CVIC Estimates
6.3 Evaluation
CVIC Estimates
6.4 Oversight and assurance

CVIC Estimates
R2.1 - 7. Vaccine Safety Surveillance and Injection Safety

CVIC Estimates

CVIC Estimates
No Fault Compensation
7.3 No fault compensation
CVIC Estimates
R2.1 - 8. Demand Generation and Communications

CVIC Estimates
A4.1-J Central Operational Expenditures

CVIC Estimates
R2.1 - 9. Protecting Essential Health Services and Health Systems Strengthening

CVIC Estimates
A4.1-K Opportunistic co-delivery of essential health services

Results-based Financing

 
Next ##<'H1 Results
2021'> ##<'H2
Help
2021'> ##<'H1 2022'> ##<'H2 2022'>
Page
in R2.1) to financing sources. Financing sources can be domestic, a partner, or a consortium of partners (incl. 'domestic').
country can be added in the beige cells below.
[Column K] to a financing source to view the implications of such a domestic and partner finance mapping, in order to inform a dialogue between rel
e allocation in Column K has been performed.
H1 2021 H2 2021 H1 2022 H2 2022

#N/A #N/A #N/A #N/A
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
in R2.1) to a budgetary unit, through which such financing will flow. These can included various ministries, departments, or other government or qua
eige cells below.
Column L] to a unit / agent to view the implications of the vaccine financing architecture, which can then be contexualized against pre-existing absopr
H1 2021 H2 2021 H1 2022 H2 2022
#N/A #N/A #N/A #N/A
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
#N/A #N/A #N/A #N/A
Override Here Global Health Expenditure Database (2018)

USD #N/A
USD #N/A
USD #N/A
USD #N/A
USD #N/A
USD #N/A
USD #N/A
USD #N/A WEO 2020-10, IFS GGX
2021 2022
#N/A #N/A
#N/A #N/A
$ - $ -
#N/A #N/A
#N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
#N/A #N/A
H1 2021 H2 2021 H1 2022 H2 2022
#N/A $ - $ - $ -
#N/A $ - $ - $ -
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A #N/A #N/A #N/A

H1 2021 H2 2021 H1 2022 H2 2022
and expected uptake - FYI only
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
pping are included)

$ - $ -
$ - $ - $ - $ -
$ - $ - $ - $ -
#N/A #N/A
ing are costed separately)

$ -
#N/A
#N/A #N/A
$ -
$ -
$ - $ -
$ - $ - $ - $ -
#N/A #N/A #N/A #N/A
$ - $ -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

$ - $ -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

H1 2021 H2 2021 H1 2022 H2 2022
#N/A $ - $ - $ -
#N/A
#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

$ - $ -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

H1 2021 H2 2021 H1 2022 H2 2022
#N/A
#N/A
#N/A
#N/A
#N/A
#VALUE!
#N/A $ - $ - $ -
#N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
$ - #N/A $ - $ -
#N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A $ - $ - $ -
#N/A
#N/A $ - $ - $ -
#N/A
#N/A #N/A #N/A #N/A

$ - $ -
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A $ - $ - $ -
#N/A
#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A
#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A

#N/A #N/A #N/A #N/A
#N/A #N/A #N/A #N/A
##<'H1 2023'> ##<'H2 2023'> ##<'TOTAL'> ##<'RO
form a dialogue between relevant stakeholders. Items can be deliberately unallocated (Column K left blank) if there
H1 2023 H2 2023 Total

#N/A #N/A #N/A
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
or other government or quasi-governmental entities. In some context, private or civil society actors may also play
against pre-existing absoprtion capacity, sustainability, etc. Please do not change the name of the unit / agent once
H1 2023 H2 2023 Total
#N/A #N/A #N/A
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
$ - $ - $ -
#N/A #N/A #N/A
Used for calculations

#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
2023
#N/A
#N/A
$ -
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
#N/A
H1 2023 H2 2023 Total
$ - $ - #N/A ##<'1_final'>
$ - $ - #N/A ##<'1_cvic'>
##<'1_override'>
#N/A ##<'1.1_cvic
#N/A ##<'1.2_cvic
#N/A ##<'1.3_cvic
#N/A ##<'1.4_cvic
#N/A ##<'1.5_cvic
#N/A ##<'1.6_cvic
#N/A ##<'1.7_cvic
#N/A #N/A #N/A ##<'2_final'>

H1 2023 H2 2023 Total
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A
$ -
$ - $ - $ - ##<'2.1_final'>
$ - $ - $ - ##<'2.1_cvic'>
Leave Blank ##<'2.1_override'>
$ -
#N/A
#N/A
$ -
$ -
$ -
$ - $ - $ -
#N/A #N/A #N/A
$ -
#N/A #N/A #N/A ##<'2.2_final'>
#N/A #N/A #N/A ##<'2.2_cvic'>
#N/A #N/A #N/A

$ -
#N/A #N/A #N/A ##<'2.3_final
#N/A #N/A #N/A ##<'2.3_cvic'>
#N/A #N/A #N/A ##<'3_final_total'>

H1 2023 H2 2023 Total
$ - $ - #N/A ##<'3.1_final
#N/A ##<'3.1_cvic'>
#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'3.2_final
#N/A #N/A #N/A ##<'3.2_cvic'>
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'3.3_final
#N/A #N/A #N/A ##<'3.3_cvic'>
#N/A #N/A #N/A ##<'3.4_final

#N/A #N/A #N/A ##<'3.4_cvic'>

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'4.1_final
#N/A #N/A #N/A ##<'4.1_cvic'>
#N/A #N/A #N/A

$ -
#N/A #N/A #N/A ##<'4.2_final
#N/A #N/A #N/A ##<'4.2_cvic'>
#N/A #N/A #N/A ##<'4.3_final

#N/A #N/A #N/A ##<'4.3_cvic'>
#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'4.4_final
#N/A #N/A #N/A ##<'4.4_cvic'>

H1 2023 H2 2023 Total
#N/A
#N/A
#N/A
#N/A
#N/A
#VALUE!
$ - $ - #N/A ##<'5.1_final
#N/A ##<'5.1_cvic'>
#N/A #N/A #N/A

#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'5.2_final
#N/A #N/A #N/A ##<'5.2_cvic'>

#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'6.1_final
#N/A #N/A #N/A ##<'6.1_cvic'>
#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'6.2_final
#N/A #N/A #N/A ##<'6.2_cvic'>
$ - $ - #N/A ##<'6.3_final
#N/A ##<'6.3_cvic'>
#N/A #N/A #N/A ##<'6.4_final

#N/A #N/A #N/A ##<'6.4_cvic'>

$ - $ - #N/A ##<'7.1_final
#N/A ##<'7.1_cvic'>
$ - $ - #N/A ##<'7.2_final
#N/A ##<'7.2_cvic'>
#N/A #N/A #N/A

$ -
#N/A #N/A #N/A ##<'7.3_final
#N/A #N/A #N/A ##<'7.3_cvic'>

$ - $ - #N/A ##<'8.1_final
#N/A ##<'8.1_cvic'>
#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A ##<'8.2_final
#N/A #N/A #N/A ##<'8.2_cvic'>
#N/A #N/A #N/A ##<'9_final_t

#N/A #N/A #N/A ##<'9_cvic'>
Leave Blank ##<'9_override'>
#N/A
#N/A #N/A #N/A
#N/A #N/A #N/A population'>

#N/A #N/A ##<'fully_immunized_persons'>
#N/A #N/A ##<'doses_delivered'>
##<'metadata_cvic_version',scalar>
##<'metadata_language',scalar>
##<'metadata_countrycode',scalar>
##<'metadata_currency',scalar>
##<'metadata_vaccine_database_update',scalar>
##<'metadata_currency_update',scalar>
##<'metadata_errors_A3',scalar>
##<'metadata_errors_B1',scalar>
##<'metadata_errors_B1_supply_demand',scalar>
##<'metadata_errors_B4',scalar>
##<'metadata_fully_immunized_persons',scalar>
##<'metadata_doses',scalar>
##<'metadata_excel_version',scalar>
##<end>
##<'SCALAR_METADATA'>
Total (2021-2023), by financing source
Domestic GAVI
WB IADB
ADB AfDB
Consortium A: e.g. Consortium B
Total (2021-2023), by financing source
GAVI/WB
Consortium C Single-Donor A
Donor B Donor C
Donor D Donor E
Financing sources, by time period

Financing sources, by time period
$1
$1
$1 Donor E Donor D
$1 Donor C Donor B
Single-Donor A Consortium C
$1
Consortium B Consortium A: e.g.
$1 GAVI/WB
$0 AfDB ADB
$0 IADB WB
$0 GAVI Domestic
$0
$-
H1 H2 H1 H2 H1 H2
2021 2021 2022 2022 2023 2023
Covid-19 vaccination financing against selected health
financing indicators
1200.0%
1000.0% Grand Total as % of 2018

GGHED +DAH
800.0% Domestic as % of 2018
GGHED
600.0% External as % of 2018 EXT
400.0%
200.0%
0.0%
2021 2022 2023
Covid-19 vaccination financing against selected health financing indicators
1 2
Budgetary Unit /
Financing Source Financing Agent
NOTE: Cells left blank imply the cost item is not allocated to R2.0.1 or R 2.0.2
##<'1_final'>
Select
Select
Here
Here
##<'1_cvic'>
##<'1_override'>
Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - A

Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - B
Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - C
Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - D
Domestic Ministry of Health
Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - E
Domestic Ministry of Health Technical Assistance - VIRAF-VIRAT 2.0 - H
##<'2_final'>
GAVI Ministry of Health
##<'2.1_final'>
##<'2.1_cvic'>
##<'2.1_override'>

Domestic Ministry of Health This is paid in Q4 2020 but added to H1 2021
##<'2.2_final'>
##<'2.2_cvic'>
##<'2.2_override'>

##<'2.3_cvic'>
##<'2.3_override'>
##<'3_final_total'>

##<'3.1_cvic'>
##<'3.1_override'>
VIRAF-VIRAT 2.0 - F4, NDVP

##<'3.2_cvic'>
##<'3.2_override'>
Note, the HRH salaries above are only paid for the period the non-redeployed vaccinator is actively
##<'3.3_cvic'>
##<'3.3_override'>

##<'3.4_cvic'>
##<'3.4_override'>
##<'4_final_total'>

##<'4.1_cvic'>
##<'4.1_override'>

##<'4.2_cvic'>
##<'4.2_override'>

##<'4.3_cvic'>
##<'4.3_override'>
Technical Assistance - VIRAF-VIRAT 2.0 - F3

##<'4.4_cvic'>
##<'4.4_override'>
##<'5_final_total'>

##<'5.1_cvic'>
##<'5.1_override'>

##<'5.2_cvic'>
##<'5.2_override'>
##<'6_final_total'>

##<'6.1_cvic'>
##<'6.1_override'>
##<'6.2_cvic'>
##<'6.2_override'>

##<'6.3_cvic'>
##<'6.3_override'>
Domestic Ministry of Health Gavi request

##<'6.4_cvic'>
##<'6.4_override'>
##<'7_final_total'>
##<'7.1_cvic'>
##<'7.1_override'>

##<'7.2_cvic'>
##<'7.2_override'>

##<'7.3_cvic'>
##<'7.3_override'>
##<'8_final_total'>
Domestic Ministry of Health VIRAF-VIRAT 2.0 - J
##<'8.1_cvic'>
##<'8.1_override'>

##<'8.2_cvic'>
##<'8.2_override'>

##<'9_cvic'>
##<'9_override'>
2.1
English
#N/A
0
26 February 2021
2021-04-23
20
1
6
0
#N/A
#N/A
20(Build:2)
User Notes
ancing against selected health financing indicators
User Notes
F-VIRAT 2.0 - A
F-VIRAT 2.0 - B
F-VIRAT 2.0 - C
F-VIRAT 2.0 - D
F-VIRAT 2.0 - E
F-VIRAT 2.0 - H
added to H1 2021
added to H1 2021
added to H1 2021
e are only paid for the period the non-redeployed vaccinator is actively vaccinating and stops when the vaccinator is no longer needed for vaccination.
F-VIRAT 2.0 - F3
NAVIGATION BAR:   
Menu Results Help
T1. Vaccine Database

Note: Advanced end users may use vaccine database row #21 (RED ARROW) onwards to specify user defined vaccines. The first 2
LAST UPDATE: 26 February 2021 Notice: Prices not publicly known - average of US$7 per d
Units:
USD
Final Price Doses per Doses per

# Vaccine Code Name Manufacturer per Dose Course Vial
1 BNT162b2 (Comirnaty) Pfizer-BionTech 7 2 6
2 ChAdOx1-S (COVISHIELDAstraZeneca 7 2 10
3 mRNA-1273 Moderna 7 2 10
4 Ad26.COV2.S J&J 14 1 5
5
6
7
8
9
10
11
12
13
14
15
Input Here
16
17
18
19
20
21 User Defined Vaccine 1
22 …
23 …
24 …
25
26
27
28
29
30

Help
cify user defined vaccines. The first 20 vaccines are auto-updateable and should not be edited.
icly known - average of US$7 per dose assumed. Vaccine specifications are indicative and
Investigable
cm3 in secondary reactions per
packaging g per dose Mins per Dose 100,000 doses
AEFI
Cold-Chain Packed Volume Investigation
Route Requirements per Dose Weight HCW Time Rate
IM (intramuscularUltra-cold (-60 to 1.8 2 10 548
IM (intramuscularRefrigerated (2 to2.1 2 10 0
IM (intramuscularFrozen (-20C) 4.96 2 10 0
IM (intramuscularRefrigerated (2 to4.6 2 10 0
Consumables per dose, including wastage factor
Low Dead Space Alcohol Swab, Sodium Chloride

Syringe (0.3ml) Syringe (0.5ml) Plaster, Dry 0.9 % ampule
AD AD 23G needle Swabs 21G needle 10mls
1.05 0 1.05 1.05 0.175 0.315
0 1.05 1.05 1.05 0 0
0 1.05 1.05 1.05 0 0
0 1.05 1.05 1.05 0 0
Fraction of a 5L
safety box occupied
to dispose of one
dose worth of
e factor medical waste
RUP syringe Sharps Disposal Vaccination Electronic

(3ml) … … (5L) Card Records
0.175 0 0 0.01 1.05 1
0 0 0 0.01 1.05 1
0 0 0 0.01 1.05 1
0 0 0 0.01 1.05 1
USD
No fault
compensation
fund
0.05
0.05
0.05
0.05
These rows are auto-updated
Sources: https://www.who.int/immunization_standards/vaccine_quality/who_pqs_e10_sb01.pdf
https://www.who.int/vaccine_safety/initiative/tools/vaccinfosheets/en/
https://www.who.int/vaccine_safety/initiative/tools/Influenza_Vaccine_rates_information_sheet.pdf
https://www.who.int/immunization_standards/vaccine_quality/Vaccines_Shipping_Guidelines082019.pdf Class A -
Max +8C; Class B - Max +30; Class C - Max +30 Min +2
Notes
End users may use thisand the next 9 rows to specify user-defined vaccines

WHO 2019 NCoV Vaccine Deployment Tool 2021.2 Eng

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

WHO 2019 NCoV Vaccine Deployment Tool 2021.2 Eng

Uploaded by

Copyright:

Available Formats

 

NAVIGATION BAR: Menu Next Page

Last Update (Vaccine database) 26 February 2021

E-mail Address for Support: CVICosting@who.int

7. Additional minor clarifications and Notes a

A1.3 Quick Links Menu

A2 INPUT Population & Delivery

ction and deployment Costing tool (CVIC Tool) Start Page

Please check and confirm that

vaccination costing estimation tool: The tool is meant to help governments,

on typical conditions: As a global/regional cost estimation tool, the costing model

uctions, cautions, and notes.

splay calculations. This is informational only and should not be edited.

Description Is user input needed?

Note: CVIC v2.1 require

A2.1 Country Paramenters

Health Financing Context (Informational Only)

Healthcare Infrastructure (FYI Only)

A2.2 Identification of Target Populations for Stages I - III

A2.3 Delivery Parameters

Distribution and Service Points

Logistics and Cold Chain

A2.4 Vaccine Selection, Wastage, and Expected Uptake

Vaccine Wastage (for demand estimations)

A2.6 Vaccine Supply

A2.6.1 Covax Vaccine Supply for 2021 only

Gavi COVAX Advance Market Commitment (AMC) Countries

Committed Purchase Arrangement (CPA)

Optional Purchase Agreement (OPA)

A2.6.3 Total Available Vaccine Supply, 2021-2023

2. Country Context, Target Population, Delivery Parameters, and Vaccine Supply

A2.1 Country Paramenters

Health Financing Context (Informational Only)

Healthcare Infrastructure (FYI Only)

A2.2 Identification of Target Populations for Stages I - III

Note: Please do not double count high-risk age groups here

Select age cut-off

1. Those who live in accessible communities,

2. Those who live in residential facilities / refugee camps,

3 Special populations who are Hard-to-Reach,

General hard-to-reach population | Delivery Modality 4 - voluntary eligibility

Rural population - FYI only

Logic checks for target population specifications - no data entry required

A2.3 Delivery Parameters

Maximum redeployable HRH, % of health workforce … as absolute number OR

Working Hours per Day

Distribution and Service Points

What percent of the hard-to-reach population vaccinated by outreach:

For vaccinations during campaigns and at residential institutions:

For vaccination by outreach:

Logistics and Cold Chain

A2.4 Vaccine Selection, Wastage, and Expected Uptake

Delivery Modality 1: Fixed sites with cold-storage

Vaccine Wastage Rate - for Delivery Modality:

A2.6 Vaccine Supply

A2.6.1 Covax Vaccine Supply for 2021 only

Covax Request or, when confirmed, Allocation

Stage 1 (H1 2021)

Gavi COVAX Advance Market Commitment (AMC) Countries

Committed Purchase Arrangement (CPA)

Optional Purchase Agreement (OPA)

A2.6.2 Non-Covax Vaccine Supply (2021-2023)

Total cost of the non-Covax vaccine doses, USD

A2.6.3 Total Available Vaccine Supply, 2021-2023